KR20120135550A - Composition for skin external application comprising culture extract of rosa placenta and functional food comprising the same - Google Patents
Composition for skin external application comprising culture extract of rosa placenta and functional food comprising the same Download PDFInfo
- Publication number
- KR20120135550A KR20120135550A KR1020110054325A KR20110054325A KR20120135550A KR 20120135550 A KR20120135550 A KR 20120135550A KR 1020110054325 A KR1020110054325 A KR 1020110054325A KR 20110054325 A KR20110054325 A KR 20110054325A KR 20120135550 A KR20120135550 A KR 20120135550A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- extract
- composition
- rose
- functional food
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 140
- 239000000203 mixture Substances 0.000 title claims abstract description 95
- 235000013376 functional food Nutrition 0.000 title claims abstract description 37
- 210000002826 placenta Anatomy 0.000 title abstract description 7
- 235000011449 Rosa Nutrition 0.000 title description 9
- 241000220317 Rosa Species 0.000 claims abstract description 100
- 210000003491 skin Anatomy 0.000 claims abstract description 78
- 239000000843 powder Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 210000004927 skin cell Anatomy 0.000 claims abstract description 12
- 108010035532 Collagen Proteins 0.000 claims abstract description 10
- 102000008186 Collagen Human genes 0.000 claims abstract description 10
- 229920001436 collagen Polymers 0.000 claims abstract description 10
- 230000004663 cell proliferation Effects 0.000 claims abstract description 9
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 8
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 7
- 230000002708 enhancing effect Effects 0.000 claims abstract 3
- 238000002360 preparation method Methods 0.000 claims description 34
- 230000003078 antioxidant effect Effects 0.000 claims description 32
- 235000013305 food Nutrition 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 230000006872 improvement Effects 0.000 claims description 25
- 239000003963 antioxidant agent Substances 0.000 claims description 21
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 13
- 101710098940 Pro-epidermal growth factor Proteins 0.000 claims description 13
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims description 13
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims description 13
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 13
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 13
- 239000008213 purified water Substances 0.000 claims description 12
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 11
- 235000013361 beverage Nutrition 0.000 claims description 11
- 210000000115 thoracic cavity Anatomy 0.000 claims description 10
- 208000026278 immune system disease Diseases 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 210000001672 ovary Anatomy 0.000 claims description 7
- 230000009759 skin aging Effects 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007902 hard capsule Substances 0.000 claims description 6
- 239000007901 soft capsule Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 238000002137 ultrasound extraction Methods 0.000 claims description 6
- 230000008929 regeneration Effects 0.000 claims description 5
- 238000011069 regeneration method Methods 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 235000014510 cooky Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 235000015895 biscuits Nutrition 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000008274 jelly Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 230000037208 balanced nutrition Effects 0.000 claims description 2
- 235000019046 balanced nutrition Nutrition 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 30
- 238000004519 manufacturing process Methods 0.000 abstract description 29
- 230000035755 proliferation Effects 0.000 abstract description 7
- 210000002510 keratinocyte Anatomy 0.000 abstract description 6
- 238000012258 culturing Methods 0.000 abstract description 5
- 230000002062 proliferating effect Effects 0.000 abstract description 5
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 230000001172 regenerating effect Effects 0.000 abstract description 2
- 210000005059 placental tissue Anatomy 0.000 abstract 4
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 230000036560 skin regeneration Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 98
- 241000196324 Embryophyta Species 0.000 description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 23
- 239000002537 cosmetic Substances 0.000 description 23
- -1 sucrose ester Chemical class 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 235000006708 antioxidants Nutrition 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 102000004127 Cytokines Human genes 0.000 description 17
- 108090000695 Cytokines Proteins 0.000 description 17
- 210000003754 fetus Anatomy 0.000 description 16
- 239000002609 medium Substances 0.000 description 13
- 235000011187 glycerol Nutrition 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 238000000605 extraction Methods 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 8
- 239000008194 pharmaceutical composition Substances 0.000 description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- 108090001005 Interleukin-6 Proteins 0.000 description 7
- 108090001007 Interleukin-8 Proteins 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 7
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 7
- 229930003935 flavonoid Natural products 0.000 description 7
- 150000002215 flavonoids Chemical class 0.000 description 7
- 235000017173 flavonoids Nutrition 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000003381 stabilizer Substances 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 101150021185 FGF gene Proteins 0.000 description 6
- 235000004347 Perilla Nutrition 0.000 description 6
- 244000124853 Perilla frutescens Species 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 235000013373 food additive Nutrition 0.000 description 6
- 239000002778 food additive Substances 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 238000004161 plant tissue culture Methods 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229920001353 Dextrin Polymers 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- 244000181025 Rosa gallica Species 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 230000002421 anti-septic effect Effects 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 239000000686 essence Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 229940029079 rose petal extract Drugs 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 229930000044 secondary metabolite Natural products 0.000 description 5
- 235000013599 spices Nutrition 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- 241001278881 Rosa foetida Species 0.000 description 4
- 241000109329 Rosa xanthina Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000006870 ms-medium Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 229940032147 starch Drugs 0.000 description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- GFVYDNHWTCHDSN-UHFFFAOYSA-N 14-methylpentadecyl octanoate Chemical compound CCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C GFVYDNHWTCHDSN-UHFFFAOYSA-N 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 235000000662 Rosa banksiae Nutrition 0.000 description 3
- 241001278830 Rosa banksiae Species 0.000 description 3
- 235000000520 Rosa foetida Nutrition 0.000 description 3
- 240000002289 Rosa odorata Species 0.000 description 3
- 244000018676 Rosa sp Species 0.000 description 3
- 235000004789 Rosa xanthina Nutrition 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 3
- 230000028709 inflammatory response Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 108090000672 Annexin A5 Proteins 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 239000004097 EU approved flavor enhancer Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- 235000000533 Rosa gallica Nutrition 0.000 description 2
- 235000000654 Rosa luciae Nutrition 0.000 description 2
- 240000003746 Rosa majalis Species 0.000 description 2
- 235000016555 Rosa majalis Nutrition 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 2
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 238000002792 antioxidant assay Methods 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 230000036570 collagen biosynthesis Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000019264 food flavour enhancer Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 230000037330 wrinkle prevention Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000015873 Antidesma dallachyanum Nutrition 0.000 description 1
- 244000159188 Antidesma dallachyanum Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 102000003685 Fibroblast growth factor 14 Human genes 0.000 description 1
- 108090000046 Fibroblast growth factor 14 Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 235000014494 Rosa brunonii Nutrition 0.000 description 1
- 241000252849 Rosa brunonii Species 0.000 description 1
- 235000000539 Rosa canina Nutrition 0.000 description 1
- 240000008530 Rosa canina Species 0.000 description 1
- 235000000664 Rosa chinensis Nutrition 0.000 description 1
- 240000008254 Rosa chinensis Species 0.000 description 1
- 235000013932 Rosa davurica Nutrition 0.000 description 1
- 241000675183 Rosa davurica Species 0.000 description 1
- 235000010337 Rosa dumalis Nutrition 0.000 description 1
- 235000000103 Rosa fedtschenkoana Nutrition 0.000 description 1
- 241000593533 Rosa fedtschenkoana Species 0.000 description 1
- 241001225283 Rosa fujisanensis Species 0.000 description 1
- 235000010075 Rosa gigantea Nutrition 0.000 description 1
- 235000000523 Rosa glauca Nutrition 0.000 description 1
- 241001278847 Rosa glauca Species 0.000 description 1
- 235000004815 Rosa hugonis Nutrition 0.000 description 1
- 241000109371 Rosa hugonis Species 0.000 description 1
- 235000002315 Rosa hybrid cultivar Nutrition 0.000 description 1
- 244000037691 Rosa hybrida Species 0.000 description 1
- 235000000661 Rosa laevigata Nutrition 0.000 description 1
- 241001278833 Rosa laevigata Species 0.000 description 1
- 235000015027 Rosa luciae var fujisanensis Nutrition 0.000 description 1
- 241001278837 Rosa lucieae Species 0.000 description 1
- 235000000657 Rosa moschata Nutrition 0.000 description 1
- 235000000656 Rosa multiflora Nutrition 0.000 description 1
- 244000050053 Rosa multiflora Species 0.000 description 1
- 235000004827 Rosa nitida Nutrition 0.000 description 1
- 241000109398 Rosa nitida Species 0.000 description 1
- 235000004828 Rosa odorata Nutrition 0.000 description 1
- 235000004779 Rosa primula Nutrition 0.000 description 1
- 241000109415 Rosa primula Species 0.000 description 1
- 240000002547 Rosa roxburghii Species 0.000 description 1
- 235000000640 Rosa roxburghii Nutrition 0.000 description 1
- 235000015054 Rosa roxburghii var hirtula Nutrition 0.000 description 1
- 240000004567 Rosa roxburghii var. hirtula Species 0.000 description 1
- 235000000659 Rosa rugosa Nutrition 0.000 description 1
- 240000006066 Rosa rugosa Species 0.000 description 1
- 235000009791 Rosa sp Nutrition 0.000 description 1
- 235000000529 Rosa virginiana Nutrition 0.000 description 1
- 240000001152 Rosa virginiana Species 0.000 description 1
- 241000806737 Rosa wichuraiana Species 0.000 description 1
- 235000005073 Rosa x alba Nutrition 0.000 description 1
- 241000109463 Rosa x alba Species 0.000 description 1
- 241000914160 Rosa x centifolia Species 0.000 description 1
- 235000001659 Rosa x odorata nothovar gigantea Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000001164 bioregulatory effect Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- CQAIPTBBCVQRMD-UHFFFAOYSA-L dipotassium;phosphono phosphate Chemical compound [K+].[K+].OP(O)(=O)OP([O-])([O-])=O CQAIPTBBCVQRMD-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910001867 inorganic solvent Inorganic materials 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000004993 mammalian placenta Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229960000540 polacrilin potassium Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Polymers [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- WVWZXTJUCNEUAE-UHFFFAOYSA-M potassium;1,2-bis(ethenyl)benzene;2-methylprop-2-enoate Chemical compound [K+].CC(=C)C([O-])=O.C=CC1=CC=CC=C1C=C WVWZXTJUCNEUAE-UHFFFAOYSA-M 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000035040 seed growth Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000006211 transdermal dosage form Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 장미 태좌 조직 배양물 또는 그 추출물을 함유하는 피부 외용제 조성물, 및 이를 함유한 기능성 식품에 관한 것이다.
The present invention relates to a composition for external application for skin containing a rose threshing tissue culture or an extract thereof, and a functional food containing the same.
전 세계적으로 약 30만종의 식물이 알려져 있으며, 다양한 생리활성을 나타내는 유용성분들이 식물에 함유되어 있음이 밝혀지고 있다. 그 유용성분들은 세포의 정상적인 대사과정에서 부차적으로 생산되어 세포 내 특수한 장소에 축적되는 2차 대사산물로서, 생화학적 또는 생태학적 관점에서 볼 때 미생물이나 외부 동물들로부터 식물체 자신을 방어하거나 생리활성 면에서 유리한 물질이라는 점에서 관심이 커지고 있다. 식물이 생산하는 2차 대사산물로는 알칼로이드(alkaloids), 플라보노이드(flavonoids), 카로티노이드(carotenoids), 글리코사이드(glycosides), 테르페노이드(terpenoids) 등이 있다. 이러한 2차 대사산물에는 보습, 피부진정 및 수렴, 자외선 차단, 미백, 각질제거, 피부노화 방지, 항산화, 피부주름 개선, 항균, 항염, 항암 등의 효과를 나타내는 것들이 많다.About 300,000 kinds of plants are known around the world, and it is found that the plants contain useful components that exhibit various physiological activities. These useful components are secondary metabolites that are produced secondary to the normal metabolism of cells and accumulate in specific places within the cell. From a biochemical or ecological point of view, they are used to protect the plant itself from microorganisms or external animals, There is a growing interest in that it is an advantageous material. Secondary metabolites produced by plants include alkaloids, flavonoids, carotenoids, glycosides, and terpenoids. These secondary metabolites have many effects such as moisturizing, soothing and converging skin, UV protection, whitening, exfoliation, skin aging prevention, antioxidant, skin wrinkle improvement, antibacterial, anti-inflammatory, anti-cancer.
식물체로부터 배주가 자방안에 붙어 있는 자리인 태좌를 적출 분리하여 기내배양 즉, 영양분이 함유되어 있는 배지에 무균적으로 배양하는 식물조직배양기술을 통하여 이차대사산물(Secondary metabolites)인 생리활성물질을 생산한다. 식물조직배양을 통하면 식물의 기관·조직· 및 세포를 공장처럼 조직배양에 의하여 유용한 물질을 대량으로 생산하는 기술이 발달되어 있기 때문에 식물로부터 직접 추출하기에 그 함량이 너무 낮고, 식물체의 부위별로는 생산성이 다르게 나타나기도 하고 혹은 기후, 계절, 장소 등의 영향에 의해 식물의 생육이 제한되는 등 많은 제약조건들을 식물세포 배양시스템의 개발로 극복됨으로써 뛰어난 생리활성효과를 보이는 2차 대사산물의 상업적 생산이 가능하다. The bioactive substance, which is a secondary metabolites, is extracted through in-flight cultivation, that is, cultivation aseptically in a nutrient-containing medium. To produce. Through plant tissue culture, the technology for producing a large amount of useful substances by tissue culture, such as a plant, has been developed so that its contents are too low to be extracted directly from the plant. The production of secondary metabolites with excellent physiological activity by overcoming many constraints, such as different productivity or limited plant growth under the influence of climate, season, location, etc. This is possible.
한편, 산업이 발달함에 따라 환경 오염이 심각해지고, 피부의 노화 방지, 미백 등에 관한 관심이 고조되면서, 자외선차단, 피부 진정 및 수렴, 항산화, 피부주름개선 등을 위한 제품 개발에 많은 노력을 기울이고 있는 실정이고, 특히 태반 유래 추출물을 이용한 화장품 제조 등이 시도되고 있으나, 소를 비롯한 동물 유래 태반 추출물은 BSE(Bovine Spongiform Encephalopathy), 돼지의 경우 콜레라 등의 병원성 및 알레르기의 문제가 염려되고 있어, 인간을 포함한 포유류 태반으로부터 직접적으로 추출하여 화장품 원료로 이용하는 경우, 그 추출방법에 따라 피부미용에 관여하지 않은 다량의 불순물이 포함될 수 있으며, 피부 특히 피부 상처가 있는 경우 면역 거부 반응을 초래할 염려가 있고, 특히 인태반인 경우에는 윤리적 문제의 이유로 인태반 추출물이 함유된 화장품의 판매가 제도적으로 금지되어 있다. 이에 반해 식물 태좌 추출물을 이용한 피부 외용제 조성물이나 기능성 식품에 관한 개발은 미비한 실정이다.
On the other hand, as the industry develops, environmental pollution becomes serious and interests on anti-aging, whitening, etc. of the skin are increasing, and efforts are being made to develop products for sun protection, soothing and converging skin, antioxidant, and wrinkle improvement. In particular, cosmetic preparation using placenta-derived extracts has been attempted, but animal-derived placenta extracts are concerned about pathogenic and allergic problems such as Bovine Spongiform Encephalopathy (BSE) and cholera in pigs. When directly extracted from the mammalian placenta including cosmetic ingredients, according to the extraction method may contain a large amount of impurities not involved in skin care, there is a risk of causing an immune rejection reaction, especially in the case of skin, especially skin wounds, In placenta, for reasons of ethics, The sale of cosmetics is systematically prohibited. On the other hand, the development of the external preparation composition or functional food using the plant pollen extract is insufficient.
본 발명자들은 피부개선능이 있는 피부 외용제 조성물 또는 식품을 제조하기 위해 노력하던 중, 장미의 태좌조직을 분리하고, 식물조직배양을 통해 배양하여 장미의 태좌조직 배양물 또는 그 추출물이 피부 세포의 성장 및 증식을 활성화시키고, 항산화능 및 주름개선효능이 있음을 확인함으로써, 본 발명을 완성하였다.The inventors of the present invention, while trying to manufacture a skin external preparation composition or food having a skin improvement ability, isolating the tissues of the tissues of the rose, and cultured through the plant tissue culture, the culture of the tissues of the rose or its extracts are grown and The present invention was completed by activating proliferation and confirming that there are antioxidant and anti-wrinkle effects.
따라서, 본 발명의 목적은 장미 태좌 조직 배양물 또는 그 추출물을 유효성분으로 함유하는 피부개선용 피부 외용제 조성물을 제공하는데 있다. Accordingly, it is an object of the present invention to provide a skin external preparation composition for improving skin, comprising a rose pollen tissue culture or an extract thereof as an active ingredient.
본 발명의 또 다른 목적은, 상기 장미 태좌 조직 배양물 또는 그 추출물을 유효성분으로 함유하는 기능성 식품을 제공하는데 있다.Still another object of the present invention is to provide a functional food containing the rose pollen tissue culture or its extract as an active ingredient.
본 발명의 또 다른 목적은, 상기 장미 태좌 조직 배양물 또는 그 추출물을 유효성분으로 함유하는 피부 외용제 조성물의 제조방법을 제공하는데 있다. Still another object of the present invention is to provide a method for preparing a composition for external application for skin containing the rose pollens tissue culture or extract thereof as an active ingredient.
본 발명의 또 다른 목적은, 상기 장미 태좌 조직 배양물 또는 그 추출물을 유효성분으로 함유하는 기능성 식품의 제조방법을 제공하는데 있다.
Still another object of the present invention is to provide a method for producing a functional food containing the rose pollen tissue culture or its extract as an active ingredient.
상기와 같은 목적을 달성하기 위해, 본 발명은 장미 태좌조직 배양물 또는 그 추출물을 유효성분으로 함유하는 피부개선용 피부 외용제 조성물을 제공한다. In order to achieve the above object, the present invention provides a skin external composition for improving the skin containing rose rotaceous tissue culture or its extract as an active ingredient.
본 발명은 또한, (a) 장미의 씨방내의 태좌조직을 분리하여 배양하는 단계; 및 (b) 상기 (a)단계에서 얻어진 배양물 또는 그 추출물을 함유하는 조성물을 제조하는 단계를 포함하는 장미 태좌조직의 배양물 또는 그 추출물을 함유한 피부개선용 피부 외용제 조성물의 제조방법을 제공한다. The present invention also comprises the steps of: (a) separating and cultivating the tissue in the ovary of the rose; And (b) provides a method for producing a skin external composition for skin improvement containing the culture or rose extract of the Taekwondo tissue comprising the step of preparing a composition containing the culture or extract thereof obtained in step (a). do.
본 발명은 또한, 장미 태좌조직의 배양물 또는 그 추출물을 함유하는 기능성 식품을 제공한다.The present invention also provides a functional food containing a culture of rose pollen tissue or an extract thereof.
본 발명은 또한, 장미 태좌조직의 배양물 또는 그 추출물을 함유하는 항산화용 조성물을 제공한다.
The present invention also provides a composition for antioxidant containing a culture or extract thereof of rose pollen tissue.
본 발명에 따른 장미 태좌조직 배양물 또는 그 추출물을 함유 피부 외용제 조성물은 항산화 활성이 뛰어난 장미 태좌조직 배양물 또는 그 추출물을 함유시켜 피부 세포의 성장이나 증식으로 인한 피부세포 활성화시킴으로써, 피부 재생, 항산화 및 주름개선 효과를 개선하는 탁월한 효과가 있다.
The composition for external application of the rose thoracic tissue culture or extract containing the extract according to the present invention contains the rose thoracic tissue culture or the extract having excellent antioxidant activity, thereby activating the skin cells due to the growth or proliferation of the skin cells, thereby regenerating the skin and preventing the antioxidant. And there is an excellent effect to improve the wrinkle improvement effect.
도 1은 인간각질형성세포에서의 본 발명에 따른 장미 태좌 조직 배양 추출물의 세포 증식 효과를 확인한 그래프이다.
도 2는 장미 태좌 조직 배양추출물의 항산화능을 확인한 그래프이다.
도 3은 장미 태좌 조직 배양추출물의 인간 섬유 아세포의 콜라겐 증진 효과를 확인한 그래프이다.
도 4는 장미 태좌 조직 배양 추출물의 싸이토카인 발현율을 확인한 그래프이다.Figure 1 is a graph confirming the cell proliferation effect of rose fetal tissue culture extract according to the present invention in human keratinocytes.
Figure 2 is a graph confirming the antioxidant capacity of rosettes tissue culture extract.
Figure 3 is a graph confirming the collagen enhancement effect of human fibroblasts of rosette tissue culture extract.
Figure 4 is a graph confirming the cytokine expression rate of rosette tissue culture culture extract.
본 발명은 장미 태좌조직 배양물 또는 그 추출물을 유효성분으로 함유하는 피부개선용 피부 외용제 조성물 및 그 제조방법, 이를 함유하는 기능성 식품에 관한 것이다. The present invention relates to a skin external preparation composition for improving skin containing the rose thoracic tissue culture or its extract as an active ingredient, a method for producing the same, and a functional food containing the same.
본 발명은 일 관점에서, 장미 태좌조직 배양물 또는 그 추출물을 유효성분으로 함유하는 피부개선용 피부 외용제 조성물에 관한 것이다. 구체적으로는, 상기 장미 태좌조직 배양물 또는 그 추출물은 조성물의 총 중량에 대하여 0.1 내지 10 중량%로 함유할 수 있다. 이러한 비율은 단지 바람직한 범위일 뿐이며, 예컨대, 하기 실시예에서는 0.1 내지 5중량%의 경우를 실험하였으나, 이 이외에 10중량%까지, 또는 그 이상의 20%, 30% 이상 경우도, 우수한 피부개선효과, 피부 증식, 재생, 주름개선, 항산화능을 기능을 가짐은 당업자에게 자명하다. The present invention in one aspect, the present invention relates to a skin external preparation composition for improving skin containing rose rotaceous tissue culture or extract thereof as an active ingredient. Specifically, the rose rotiferous tissue culture or its extract may be contained in an amount of 0.1 to 10% by weight based on the total weight of the composition. This ratio is only a preferred range, for example, in the following examples, the case of 0.1 to 5% by weight was tested, in addition to 10% by weight, or more than 20%, 30% or more, also excellent skin improvement effect, It is apparent to those skilled in the art that it has functions of skin proliferation, regeneration, wrinkle improvement, and antioxidant activity.
본 발명에 있어서, 상기 장미 태좌조직 배양물 (배양체) 자체를 사용하거나, 배양물을 여과하여 사용하거나, 배양물을 파쇄하여 사용하거나, 배양물을 건조시켜 분말화한 다음, 정제수에 녹여 사용할 수 있다.In the present invention, using the rosette tissue culture (culture) itself, the culture is used by filtration, the culture can be used by crushing, or the culture to dry the powder, and then dissolved in purified water can be used have.
본 발명에 있어서, "추출물"은 상기 장미 태좌조직 배양 추출물을 분말화하거나, 열수추출법, 에탄올 추출법 등 종래 알려진 다양한 추출법에 의해 수득한 추출물을 의미한다. In the present invention, "extract" refers to an extract obtained by powdering the rose pollen tissue culture extract, or by various conventionally known extraction methods such as hot water extraction, ethanol extraction.
본 발명에서 추출 방법은 특별히 제한되지 않고, 예를 들어 냉침 추출, 초음파 추출, 환류 추출, 열수 추출 등이 있다. 여기서, 초음파 추출의 경우, 초음파 발생기(Elma, Transsonic 1040/H)를 사용하여 40kHz에서 60분 동안 초음파 추출을 시행하고, 65℃에서 2 시간 동안 교반하여 반응시킨 후, 열탕증류기에서 8 ~ 48시간동안, 80 ~100 ℃로 가열하여 열수 추출물을 얻는다. The extraction method in the present invention is not particularly limited, and examples thereof include cold needle extraction, ultrasonic extraction, reflux extraction, hot water extraction, and the like. Here, in the case of ultrasonic extraction, ultrasonic extraction for 60 minutes at 40kHz using an ultrasonic generator (Elma, Transsonic 1040 / H), and stirred for 2 hours at 65 ℃ reaction, and then 8 to 48 hours in a hot water distillation machine Is heated to 80-100 ° C. to obtain a hydrothermal extract.
또는, 물, 유기 용매, 또는 이의 혼합 용매를 사용하여 추출하는 방법으로 제조될 수 있다. 추출한 액은 바로 사용하거나 또는 농축 및/또는 건조하여 사용할 수 있다. 유기용매를 사용하여 추출하는 경우, 메탄올, 에탄올, 이소프로판올, 부탄올, 에틸렌, 아세톤, 헥산, 에테르, 클로로포름, 에틸아세테이트, 부틸아세테이트, 디클로로메탄, N, N-디메틸포름아미드(DMF), 디메틸설폭사이드(DMSO), 1,3-부틸렌글리콜, 프로필렌글리콜 또는 이들의 혼합용매인 유기용매를 사용하며 생약의 유효 성분이 파괴되지 않거나 최소화된 조건에서 실온 또는 가온하여 추출할 수 있다. 추출하는 유기용매에 따라 약제의 유효성분의 추출정도와 손실정도가 차이가 날 수 있으므로, 알맞은 유기용매를 선택하여 사용하도록 한다. Or by extraction using water, an organic solvent, or a mixed solvent thereof. The extracted solution can be used directly or can be concentrated and / or dried. When extracted with an organic solvent, methanol, ethanol, isopropanol, butanol, ethylene, acetone, hexane, ether, chloroform, ethyl acetate, butyl acetate, dichloromethane, N, N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), 1,3-butylene glycol, propylene glycol, or a mixed solvent thereof may be used and extracted by room temperature or warming under conditions where the active ingredient of the herbal medicine is not destroyed or minimized. Depending on the organic solvent to be extracted, the degree of extraction and loss of the active ingredient of the drug may vary, so select an appropriate organic solvent.
본 발명에 있어서, 상기 추출물은 농축, 또는 희석하여 사용할 수 있고, 추출물의 증류액을 사용할 수도 있다.In the present invention, the extract may be used by concentration or dilution, or distillate of the extract may be used.
본 발명에 있어서, "피부개선용"이란, 피부 보호 및 피부 상태 개선, 피부 미백, 피부 노화 및 주름의 예방 또는 개선, 피부 보호 및 피부의 염증 반응의 완화, 면역질환 개선능, 또는 피부 장벽 기능 개선, 피부자극 완화, 피부 세포 증식 및 재생능, 항산화능, 콜라겐 합성 증진능 등을 모두 포함하는 개념이다.In the present invention, "for skin improvement" means skin protection and skin condition improvement, skin whitening, skin aging and wrinkle prevention or improvement, skin protection and alleviation of skin inflammatory response, immune disease improvement ability, or skin barrier function It is a concept that includes improvement, alleviation of skin irritation, skin cell proliferation and regeneration ability, antioxidant activity, and collagen synthesis enhancement ability.
본 발명에 있어서, "유효성분으로 함유하는"의 의미는, 피부 외용제 조성물로써 피부 개선 효과를 나타낼 수 있는, 예컨대, 피부 세포의 증식활성을 개선시킬 수 있고, 활성화 시킬 수 있는 정도로 함유하는 것을 의미한다. 또한, 피부 외용제 조성물로써 주름개선효능과 관련된 콜라겐 합성 또는 MMP-1,9 억제 활성을 나타낼 수 있는 정도, 또는 항산화능 효능, 또는 싸이토카인 발현능을 나타낼 수 있을 정도의 유효량을 함유하는 것을 의미한다. In the present invention, the meaning of "contained as an active ingredient" means that the composition for external application for skin can contain a skin improving effect, for example, can contain and improve the proliferative activity of skin cells. do. In addition, it means that the composition for external application for skin contains an effective amount capable of exhibiting collagen synthesis or MMP-1,9 inhibitory activity related to the anti-wrinkle effect, or an antioxidant effect or a cytokine expression ability.
본 발명에 있어서, 장미[薔薇, rose]는 쌍떡잎식물 장미목 장미과(Rosaceae) 장미속(Rosa)에 속하는 식물의 총칭하며, 관목성의 화목(花木)이다. 장미속의 식물들은 낙엽성 저목으로 때로는 덩굴성이 되고, 줄기에는 가시가 많으며, 잎은 호생(互生), 꽃은 단생 또는 꽃꼭지의 길이가 밑의 것은 길고 위로 갈수록 짧아져 각 꽃은 거의 동일 평면으로 나란히 달리는 산방상(散房狀)으로 달린다. 꽃받침과 꽃잎은 보통 5개이지만 드물게는 4개인 경우도 있다. 수술은 여러 개 있으며, 암술은 화상(花床)속에 많이 있다. 화상은 과(果), 때로는 부풀어 장과형(漿果形)으로 되고, 안에는 많은 딱딱한 수과(瘦果)를 포함하고 있다. 오늘날 장미라고 하는 것은 이들 야생종의 자연잡종과 개량종을 말한다. 각 종(種)에는 개체변이가 많으며, 종간 잡종이 되기 쉽다. 장미는 갖춘 꽃으로 꽃의 아름다운 형태와 향기 때문에 관상용과 향료용으로 재배해왔으며, 개량을 가하여 육성한 원예종(Rosa hybrida Hort.)을 말한다. 서구에서는 고대로부터 가장 사랑 받는 관상 저목이였으며 현대에 와서도 세계적으로 가장 인기가 많은 관상 저목 중의 하나이다. 서구 고대의 것은 Rosa gallica, R. centifolia, R. damascena 등이었다. 현대의 것은 중국의 월계화나 R. odorata와 지중해안의 R. gallica, R. damascena, R. moschata와의 복잡한 교배로부터 Hybrid Tea가 만들어졌다. 순황품종(純黃品種)은 이란원산의 R. foetida와 Hybrid Tea와의 교배에 의해 만들어졌다. 찔레와 월계화를 교배한 것에 Hybird Tea를 교배함으로써 꽃이 크고 다화성의 플로리번다(floribunda)가 만들어졌다.In the present invention, a rose is a generic name of a plant belonging to the dicotyledonous plant Rosaceae Rosaceae, and is a shrub-like flowering plant. Roses are deciduous trees, sometimes vines, stalks have thorns, leaves are regenerated, flowers are short-lived, or the length of the stem is shorter and shorter upwards, and each flower is almost coplanar. Run side by side on the mountain. Calyx and petals are usually five, but rarely four. There are several surgery, pistil is a lot in the burn (花 床). Burns are fruit, sometimes swollen, berry-shaped, and contain many hard fruits. Today, the rose refers to the natural hybrids and improved species of these wild species. Each species has many individual variations, and is likely to be a hybrid between species. Roses are flowers that have been cultivated for ornamental and fragrance because of their beautiful shape and fragrance. They are cultivated by the improvement of Rosa hybrida Hort. In the West, it was the most beloved ornamental plant from ancient times, and is one of the most popular ornamental plants in the world today. Western Ancient Rosa gallica , R. centifolia , R. damascena and the like. In modern times, hybrid teas were made from Chinese laurels or from the complex crosses of R. odorata and R. gallica , R. damascena and R. moschata in the Mediterranean. Pure sulfur varieties were produced by hybridization of Iranian native R. foetida and Hybrid Tea. The crossover of brier and laurel crossed Hybird Tea to produce a large, multi-flora floribunda.
본 발명에 있어서, "장미"는, 이에 제한되는 것은 아니나, Rosa gallica , Rosa centifola , Rosa damascene , Rosa chinensis , Rosa odorata , Rosa moschata , Rosa foetida , Rosa canina , Rosa rugosa, Rosa davurica Pall , Rosa multiflora , Rosa luciae , Rosa wichuraiana , Rosa gigantea , Rosa alba , Rosa primula , Rosa banksiae, Rosa Mundi , Rosa brunonii , Rosa cinnamomea , Rosa glauca , Rosa spinosissma , Rosa foetida bicolor , Rosa foetida persiana , Rosa fedtschenkoana , Rosa mulliganii, Rosa sericana pteracantha , Rosa hugonis , Rosa banksiae lutea , Rosa banksiae , Rosa roxburghii, Rosa hirtula , Rosa aciculaisis nipponensis , Rosa uchiyamana , Rosa jasminoides , Rosa fujisanensis, Rosa laevigata , Rosa cinnamomea , Rosa nitida , Rosa california , Rosa virginiana, 및 Rosa palustris를 포함한 장미속 식물이다. In the present invention, "rose" is not limited thereto, but Rosa gallica , Rosa centifola , Rosa damascene , Rosa chinensis , Rosa odorata , Rosa moschata , Rosa foetida , Rosa canina , Rosa rugosa, Rosa davurica Pall , Rosa multiflora , Rosa luciae , Rosa wichuraiana , Rosa gigantea , Rosa alba , Rosa primula , Rosa banksiae, Rosa Mundi , Rosa brunonii , Rosa cinnamomea , Rosa glauca , Rosa spinosissma , Rosa foetida bicolor , Rosa foetida persiana , Rosa fedtschenkoana , Rosa mulliganii, Rosa sericana pteracantha , Rosa hugonis , Rosa banksiae lutea , Rosa banksiae , Rosa roxburghii, Rosa hirtula , Rosa aciculaisis nipponensis , Rosa uchiyamana , Rosa jasminoides , Rosa fujisanensis, Rosa laevigata , Rosa cinnamomea , Rosa nitida , Rosa california , Rosa virginiana , and Rosa Rose genus includes palustris .
식물조직배양은 살아있는 작은 식물 조직을 기내(in vitro)에서 무균적으로 배양하여 배양 목적에 따라서 식물 세포, 기관 및 식물체를 증식 시키는 기술이다. 식물조직배양에는 식물이 지니는 기본적인 특성을 이용한다고 볼 수 있다. 식물조직배양 기술은 식물이 지니는 독특한 특징인 식물의 체세포로부터 식물체를 재생시킬 수 있는 분화전능성(totipotency)을 이용하는 것을 기반으로 하는 기술이다. 즉, 식물의 단세포(원형질체 포함), 잎 및 뿌리 절편을 특정 영양물질 및 생장 조절제가 첨가된 배지에 배양하면 이들 세포 및 조직으로부터 식물체가 재생될 수 있다. 이러한 식물이 분화전능성(totipotency)을 지니는 능력은 식물이 지니는 특성인 고착 생활과 장기간 생존을 위하여 열악한 환경 및 초식동물의 피해로부터 생존을 하기 위한 전략이다. 따라서 식물은 잃어버린 기관을 다시 재생시키기 위한 능력을 갖게 되었다고 볼 수 있다. 모식물체로부터 분리된 식물조직세포는 적정배양환경에서 배양하면 완전한 식물체로 재생될 수 있는 잠재력 즉, 전형성능을 가지고 있는 식물은 발생학 등의 학술적인 중요성은 물론이지만 화장품 원료 등의 실용화를 위해서도 활용가치가 크다.Plant tissue culture is used to keep live small plant tissues in It is a technique for growing plant cells, organs and plants according to the purpose of culture by aseptically culturing in vitro . Plant tissue culture can be said to use the basic characteristics of the plant. Plant tissue culture technology is based on the use of the totipotency that can regenerate the plant from the somatic cells of the plant, a unique feature of the plant. That is, by culturing single cells (including protoplasts), leaf and root sections of plants in a medium to which specific nutrients and growth regulators are added, the plants can be regenerated from these cells and tissues. The ability of these plants to totipotency is a strategy for surviving from the damage of the environment and herbivores for the fixed life and long-term survival of the plants. Thus, plants can be said to have the ability to regenerate lost organs. Plant tissue cells isolated from the parent plants can be regenerated into complete plants when cultured in an appropriate culture environment, that is, plants with typical properties are not only academically important in embryology but also for practical use of cosmetic raw materials. Is large.
식물의 태좌(胎座, Placenta)는 동물 유래의 태반과 같이, 종자 육성을 주관하는 중요한 부위로, 암술의 씨방(자방, 子房, Ovary)안에서 밑씨가 붙는 부분이다. 보통 씨방을 형성하는 심피(心皮, carpel)의 가장자리에 있는데, 때로는 심피의 중맥에도 있다. 또 씨방의 기저나, 기저로부터 씨방 안에 직립하는 기둥 모양으로 생길 때도 있다. Placenta of the plant, like the placenta derived from an animal, is an important site that manages seed growth, and is the part where the seed is attached in the ovary of the pistil. It is usually located at the edge of the carpel, which forms an ovary, sometimes in the middle vein of the carpel. It may also be formed in the base of the ovary or in the shape of a column standing upright in the ovary from the base.
또한, 본 발명은 다른 관점에서, (a) 장미의 태좌조직을 분리하여 배양하는 단계; 및 (b) 상기 장미 태좌조직 배양물 또는 그 추출물을 함유하는 조성물을 제조하는 단계를 포함하는 장미 태좌조직 배양물 또는 그 추출물을 함유한 피부개선용 피부 외용제 조성물의 제조방법, 장미 태좌 조직 배양물 또는 그 추출물을 함유하는 기능성 식품 제조 방법에 관한 것이다. In addition, the present invention in another aspect, the step of (a) separating and culturing the tissue of the rosette; And (b) a method for producing a skin for the improvement of skin composition containing rose rosette tissue culture or the extract comprising the step of preparing a composition containing rose rosette tissue culture or extract thereof, rosette tissue tissue culture Or it relates to a functional food production method containing the extract.
상기 (a)단계에서, 구체적으로는 장미 태좌조직을 배양하기 위해 적절한 배지를 선택할 수 있다. 기술 분야에서 식물조직배양에 일반적으로 사용되고 있는 배지가 있다면, 제한 없이 사용가능하다. 식물에서는 일반적으로 MS배지, B5배지 등을 주로 사용하고, 일 예로, MS배지의 조성(1L기준시)은 NH4NO3 1650 mg, KNO3 1900 mg, CaCl2.2H2O 440 mg, MgSO4.7H2O 370 mg, KH2PO4 170 mg, KI 0.83 mg, H3BO3 6.2 mg, MnSO4.4H2O 22.3 mg, ZnSO4.7H2O 8.6 mg, Na2MoO4.2H2O 0.25 mg, CuSO4,5H2O 0.025 mg, CoCl2.6H2O 0.025 mg, FeSO4.7H2O 27.8 mg, Na2EDTA.2H2O 37.3 mg, Myoinositol 100 mg, Nicotinic acid 0.5 mg, Pyridoxine-HCl 0.5 mg, Thiamine-HCl 0.5 mg, Glycine 2 mg, Sucrose 30000 mg 이다. In the step (a), specifically, an appropriate medium may be selected for culturing rose dorsal tissue. If there is a medium generally used for plant tissue culture in the art, it can be used without limitation. In plants, MS medium and B5 medium are generally used. For example, the composition of MS medium (1 L standard) is NH 4 NO 3 1650 mg, KNO 3 1900 mg, CaCl 2 H 2 O 440 mg, MgSO 4 .7H 2 O 370 mg, KH 2 PO 4 170 mg, KI 0.83 mg, H 3 BO 3 6.2 mg, MnSO 4 .4H 2 O 22.3 mg, ZnSO 4 .7H2O 8.6 mg, Na 2 MoO 4 .2H 2 O 0.25 mg, CuSO 4, 5H 2 O 0.025 mg, CoCl 2 .6H 2 O 0.025 mg, FeSO 4 .7H 2 O 27.8 mg, Na 2 EDTA.2H 2 O 37.3 mg,
본 발명에 있어서, 상기 (b)단계에서 있어서, (a)단계의 배양을 통해 얻어진 장미 태좌 조직 배양물 그대로를 포함하는 조성물을 적절한 형태의 피부 외용제 조성물 또는 기능성 식품으로 제조하거나, 또는 상기 배양물을 공지된 추출 방법을 통해 추출물 형태로 수득하여 적절한 형태의 피부 외용제 조성물 또는 기능성 식품으로 제조할 수 있다.예컨대, 상기 (a)단계에서 얻어진 배양물을 열풍 건조후 분말화하여 수분을 증발시키고, 필요에 따라서는, 적절한 바인더와 혼합하여 제조할 수 있다.In the present invention, in the step (b), the composition containing the rosette tissue culture culture obtained through the culture of step (a) as it is prepared in a suitable form of the external preparation composition or functional food, or the culture It can be obtained in the form of extract through a known extraction method to prepare a suitable external skin composition or functional food. For example, the culture obtained in the step (a) is powdered after hot air drying to evaporate moisture, As needed, it can manufacture by mixing with an appropriate binder.
본 발명에 있어서, 상기 바인더는 본 발명에 따른 장미 태좌 배양물 또는 그 추출물이 식품용 소재로서 제공될 경우, 예컨대, 액상체, 분말체(산제), 과립제, 정제 등의 형태로 제공될 시에, 취급의 편의성과 형성성의 향상을 위해 추가하는 첨가제이다. 이러한 바인더의 예시로써, 액체의 경우, 물, 알코올, 글리세린, 증점 다당류 등이 있으며, 분말의 경우, 유당, 전분, 덱스트린, 자당, 올리고당, 사이클로덱스트린, 셀룰로오스 유도체 등이 있고, 과립제, 정제, 캅셀 등의 경우, 유당, 전분, 덱스트린, 자당, 올리고당, 사이클로덱스트린, 셀룰로오스유도체, 자당 에스테르, 지방산 에스테르 등이 있다.In the present invention, the binder is when the rose pollen culture or the extract according to the present invention is provided as a food material, for example, when provided in the form of a liquid, powder (powder), granules, tablets, etc. It is an additive added to improve handling convenience and formability. Examples of such binders include water, alcohols, glycerin, thickened polysaccharides, and the like in powders, lactose, starch, dextrin, sucrose, oligosaccharides, cyclodextrins, cellulose derivatives, granules, tablets, and capsules. And the like, lactose, starch, dextrin, sucrose, oligosaccharide, cyclodextrin, cellulose derivative, sucrose ester, fatty acid ester and the like.
본 발명에 있어서, 상기 피부 외용제 조성물은 화장료 조성물 또는 약제학적 조성물일 수 있다.In the present invention, the composition for external application for skin may be a cosmetic composition or a pharmaceutical composition.
상기 화장료 조성물에 있어서는, 화장품 제제에 있어서 수용가능한 담체를 포함할 수 있다. 여기서, "화장품 제제에 있어서 수용가능한 담체"란 화장품 제제에 포함될 수 있는 이미 공지되어 사용되고 있는 화합물 또는 조성물이거나 앞으로 개발될 화합물 또는 조성물로서 피부와의 접촉시 인체가 적응 가능한 이상의 독성, 불안정성 또는 자극성이 없는 것을 말한다.In the cosmetic composition, an acceptable carrier may be included in the cosmetic formulation. Herein, "acceptable carrier in cosmetic preparation" means a compound or composition already known and used that may be included in a cosmetic preparation or a compound or composition which will be developed in the future, and which has no toxicity, instability or irritation that is acceptable to the human body upon contact with the skin. Say nothing.
상기 담체는 본 발명의 피부 외용제 조성물에 그것의 전체 중량에 대하여 약 1 중량 % 내지 약 99.99 중량 %, 바람직하게는 조성물의 중량의 약 90 중량% 내지 약 99.99 중량 %로 포함될 수 있다. 그러나 상기 비율은 본 발명의 피부 외용제 조성물이 제조되는 후술한 바의 제형에 따라 또 그것의 구체적인 적용 부위(얼굴, 목 등)나 그것의 바람직한 적용량 등에 따라 달라지는 것이기 때문에, 상기 비율은 어떠한 측면으로든 본 발명의 범위를 제한하는 것으로 이해되어서는 안 된다.The carrier may be included in the skin topical composition of the present invention in an amount of from about 1% by weight to about 99.99% by weight, preferably from about 90% by weight to about 99.99% by weight of the composition, based on the total weight thereof. However, since the ratio varies depending on the formulations described below in which the composition for external application for skin of the present invention is prepared, and its specific application site (face, neck, etc.) or its preferable application amount and the like, And should not be construed as limiting the scope of the invention.
상기 담체로서는 알코올, 오일, 계면활성제, 지방산, 실리콘 오일, 습윤제, 보습제, 점성 변형제, 유제, 안정제, 자외선산란제, 자외선흡수제, 발색제, 향료 등이 예시될 수 있다. 상기 알코올, 오일, 계면활성제, 지방산, 실리콘 오일, 습윤제, 보습제, 점성 변형제, 유제, 안정제, 자외선산란제, 자외선흡수제, 발색제, 향료로 사용될 수 있는 화합물/조성물 등은 이미 당업계에 공지되어 있기 때문에 당업자라면 적절한 해당 물질/조성물을 선택하여 사용할 수 있다.Examples of the carrier include an alcohol, an oil, a surfactant, a fatty acid, a silicone oil, a wetting agent, a moisturizer, a viscous modifier, an emulsifier, a stabilizer, an ultraviolet scattering agent, an ultraviolet absorber, a coloring agent and a perfume. The compounds / compositions which can be used as the above-mentioned alcohol, oil, surfactant, fatty acid, silicone oil, humectant, humectant, viscous modifier, emulsifier, stabilizer, ultraviolet scattering agent, ultraviolet absorber, The person skilled in the art can select and use the appropriate substance / composition.
본 발명의 일 구현예로써, 본 발명에 따른 피부 외용제 조성물은 상기 장미 태좌조직 배양 추출물 이외에 글리세린, 부틸렌글리콜, 프로필렌글키롤, 폴리옥시에틸렌 경화피마자유, 에탄올, 트리에탄올아민 등을 포함할 수 있으며, 방부제, 항료, 착색료, 정제수 등을 필요에 따라 미량 포함할 수 있다. As an embodiment of the present invention, the external preparation composition for skin according to the present invention may include glycerin, butylene glycol, propylene glycol, rolled polyoxyethylene hydrogenated castor oil, ethanol, triethanolamine, etc. , Preservatives, paints, colorings, purified water and the like may be included as necessary.
본 발명에 따른 피부 외용제 조성물은, 다양한 형태로 제조될 수 있는데, 예컨대, 화장수, 에센스, 젤, 에멀젼, 로션, 크림(수중유적형, 유중수적형, 다중상), 용액, 현탁액(무수 및 수계), 무수 생성물(오일 및 글리콜계), 젤, 마스크, 팩, 분말, 또는 젤라틴 등의 피막이 있는 캅셀 (소프트 캅셀, 하드 캅셀) 제형 등의 형태로 제조될 수 있다. The composition for external application for skin according to the present invention can be prepared in various forms such as lotion, essence, gel, emulsion, lotion, cream (underwater type, water type, multiphase), solution, suspension ), Capsules (soft capsules, hard capsules) having a coating such as anhydrous products (oil and glycol), gel, mask, pack, powder or gelatin.
본 발명에 있어서의 피부는 얼굴 뿐만 아니라, 두피, 전신도 포함되는 개념으로, 이러한 두피에 적용될 수 있는 피부 외용제 조성물로써, 샴푸, 린스, 트리트먼트, 발모제 등이 있고, 전신에 적용될 수 있는 바디클렌져 등의 용도로써 다양한 형태로 제조될 수 있다. The skin of the present invention includes not only the face but also the scalp and whole body. The composition for external application for skin which can be applied to such scalp includes shampoo, rinse, treatment, hair removal agent, etc., and a body cleanser And the like can be manufactured in various forms.
본 발명에 따른 장미 태좌조직 배양 추출물을 함유 피부 외용제 조성물의 제조방법은 전술한 제조방법에 한정되는 것은 아니며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 상기 제조방법을 일부 변형시킨 방법으로도 본 발명에 따른 장미 태좌조직 배양 추출물을 함유 피부 외용제 조성물을 제조할 수 있다.The method for preparing the composition for external application for skin containing rose thoracic tissue culture extract according to the present invention is not limited to the above-described preparation method, and those skilled in the art to which the present invention pertains may partially modify the preparation method. As an external composition for skin preparations containing rose fetal tissue culture extract according to the present invention can be prepared.
특히, 상기 피부 외용제 조성물은 본 발명에 특별히 개시된 제조방법 이외에도, 통상적으로 알려진 제조방법을 이용하여, 일반적인 유화 제형 및 가용화 제형의 형태로 제조될 수 있다. In particular, the external preparation composition for the skin may be prepared in the form of general emulsion formulations and solubilized formulations using a conventionally known production method, in addition to the production method specifically disclosed in the present invention.
화장료 조성물로 제조될 경우, 유화 제형의 화장품으로는 영양화장수, 크림, 에센스 등이 있으며, 가용화 제형의 화장품으로는 유연화장수가 있다. 또한, 피부과학적으로 허용가능한 매질 또는 기제를 함유함으로써 피부과학 분야에서 통상적으로 사용되는 국소적용 또는 전신적용할 수 있는 보조제 형태로 제조될 수 있다. When the cosmetic composition is prepared, cosmetics of the emulsion formulations include nutrient cosmetics, creams, essences, etc., and cosmetics of the solubilized formulations include soft cosmetics. In addition, by containing a dermatologically acceptable medium or base, it can be prepared in the form of topical or systemic adjuvants commonly used in the field of dermatology.
또한, 적합한 화장품의 제형으로는, 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실스틱의 형태로 제공될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다. In addition, formulations of suitable cosmetics include, for example, emulsions, suspensions, microemulsions, microcapsules, microgranules or ionic (liposomes), nonionics obtained by dispersing an oil phase in a solution, gel, solid or pasty anhydrous product, aqueous phase, for example. It may be provided in the form of a vesicle dispersant in the form of a cream, skin, lotion, powder, ointment, spray or concealed stick. It may also be prepared in the form of a foam or in the form of an aerosol composition further containing a compressed propellant.
또한, 본 발명의 피부 외용제 조성물은 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일,염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 그리고, 상기의 성분들은 피부과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.In addition, the topical skin composition of the present invention may further comprise fatty substances, organic solvents, solubilizers, thickeners and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, ions Any commonly used in type or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or cosmetics It may contain adjuvants conventionally used in the cosmetic or dermatology field as other ingredients. In addition, the above components may be introduced in an amount generally used in the dermatology field.
이러한, 본 발명에 따른 피부 외용제 조성물은 피부 세포 재생, 증식능이 우수하여 피부상태개선, 항산화능, 콜라겐 합성 증진능에 따른 피부 노화 방지, 피부 미백, 우수한 싸이토카인 발현능에 의한 염증의 완화/예방 등을 비롯한 면역질환 치료/예방의 기능을 할 수 있는 기능성 화장품의 형태를 포함한다.Such a composition for external application for skin according to the present invention has excellent skin cell regeneration and proliferative ability, including improvement of skin condition, antioxidant activity, prevention of skin aging according to collagen synthesis enhancement ability, skin whitening, relief of inflammation by excellent cytokine expression ability, and the like. It includes a form of functional cosmetics that can function in the treatment / prevention of immune diseases.
본 발명에 있어서, 약제학적 조성물의 경우, 하기 실시예에서 제시하는 다양한 VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 및 TNF-α 의 싸이토카인을 발현하고 있고, 특ㅎ, 그 중, EGF, TGF-β1 및 TNF-α 에 대해 우수한 수준의 싸이토카인 발현능을 가지고 있어, 면역질환 치료, 예방용 약제학적 조성물로써 기능할 수 있다. In the present invention, the pharmaceutical composition expresses various cytokines of VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 and TNF-α shown in the following Examples, In particular, it has an excellent level of cytokine expression of EGF, TGF-β1 and TNF-α, and can function as a pharmaceutical composition for treating and preventing immune diseases.
이러한 약제학적 조성물은 유효성분인 장미 태좌조직 배양물 또는 그 추출물 외에, "약학적으로 허용가능한 담체"를 포함할 수 있으며, 이러한 담체는 희석제, 활택제, 결합제, 붕해제, 감미제, 안정제 및 방부제로 이루어진 군으로부터 선택될 수 있다. . 상기 약학 조성물은 첨가제를 더 포함할 수 있다. 상기 첨가제로 향료, 비타민, 및 항산화제가 포함될 수 있다. 상기 담체로 약제학적으로 허용 가능한 담체는 모두 가능하며, 예를 들면, 희석제로는 유당, 덱스트린, 타피오카(tapioca) 녹말, 옥수수 전분, 대두유, 미정질 셀룰로오스, 또는 만니톨, 활택제로는 스테아린산 마그네슘 또는 탈크, 결합제로는 폴리비닐피롤리돈 또는 히드록시프로필셀룰로오스일 수 있다. 또한, 붕해제로는 카르복시메틸셀룰로오스 칼슘, 전분글리콜산나트륨, 폴라크릴린칼륨, 또는 크로스포비돈, 감미제로는 백당, 과당, 솔비톨, 또는 아스파탐, 안정제로는 카르복시메틸셀룰로오스나트륨, 베타-사이클로덱스트린, 또는 잔탄검, 방부제로는 파라옥시안식향산메틸, 파라옥시안식향산프로필, 또는 솔빈산칼륨일 수 있다.Such pharmaceutical compositions may comprise "pharmaceutically acceptable carriers", in addition to the active rosette tissue culture or extracts thereof, which carriers may be diluents, lubricants, binders, disintegrants, sweeteners, stabilizers and preservatives. It may be selected from the group consisting of. . The pharmaceutical composition may further comprise an additive. The additives may include flavoring agents, vitamins, and antioxidants. Examples of the diluent include lactose, dextrin, tapioca starch, corn starch, soybean oil, microcrystalline cellulose or mannitol as a carrier, magnesium stearate or talc as a lubricant, , And the binding agent may be polyvinylpyrrolidone or hydroxypropylcellulose. Examples of the disintegrant include carboxymethylcellulose calcium, sodium starch glycolate, polacrilin potassium, or crospovidone; examples of sweeteners include white sugar, fructose, sorbitol, or aspartame; stabilizers include sodium carboxymethylcellulose, Or xanthan gum, and the preservative may be methyl paraoxybenzoate, propyl p-hydroxybenzoate, or potassium sorbate.
상기 약제학적 조성물은 당해 기술분야에 공지되어 있는 통상적인 약제학적 제형으로 제제화될 수 있다. 상기 약제학적 조성물은 경구 투여제제, 주사제, 좌제, 경피 투여제제, 및 경비 투여제제의 제형으로 제제화되어 투여될 수 있다. 예를 들면, 상기 제형은 액제, 현탁제, 산제, 과립제, 정제, 캡슐제, 환제, 또는 엑스제와 같은 경구 투여용 제형일 수 있다.The pharmaceutical composition may be formulated in conventional pharmaceutical formulations known in the art. The pharmaceutical compositions may be formulated and administered in the form of oral dosages, injections, suppositories, transdermal dosage forms, and nasal dosages. For example, the formulation may be a formulation for oral administration such as liquids, suspensions, powders, granules, tablets, capsules, pills, or extracts.
다른 관점에서, 본 발명은 상기의 장미 태좌조직 배양물 또는 그 추출물을 포함하는 기능성 식품 또는 식품 첨가제에 관한 것이다.In another aspect, the present invention relates to a functional food or food additives comprising the rose rotiferous tissue culture or extract thereof.
본 발명의 장미 태좌조직 배양물 또는 그 추출물 자체는 독성 및 부작용이 거의 없으므로 안전하게 식품에 사용할 수 있다.Rose tissue of the present invention or the extract itself is almost no toxicity and side effects can be used safely in food.
본 발명에서 용어,"기능성식품(functional food)"은 특정보건용 식품(food for special health use, FoSHU)와 동일한 용어로, 영양 공급 외에도 생체조절기능이 효율적으로 나타나도록 가공된 의학, 의료효과가 높은 식품을 의미한다. 본 발명에서 "기능성 식품"이라는 용어에는, 건강식품, 건강보조식품이라는 용어와 호용된다. "건강식품(health food)"은 일반식품에 비해 적극적인 건강유지나 증진 효과를 가지는 식품을 의미하고, 건강보조식품(health supplement food)는 건강 보조 목적의 식품을 의미한다. 이러한 기능성 식품은 피부 미백, 주름개선, 항산화능 등의 효과를 얻기 위하여 정제, 소프트캅셀, 하드캅셀, 분말, 과립, 액상, 환, 음료, 젤리, 구미, 캔디, 쿠키, 비스켓, 에네르기바 등의 밸런스 영양 식품등의 다양한 형태로 제조될 수 있다.In the present invention, the term "functional food" is the same term as food for special health use (FOSHU), in addition to the nutritional supply, the processed food, medical effect is effectively processed to appear bioregulatory function It means high food. In the present invention, the term "functional food" is used interchangeably with the terms health food, health supplement food. "Health food (health food)" means a food that has an active health maintenance or promotion effect compared to the general food, health supplement food (health supplement food) means a food for health supplement purposes. These functional foods include tablets, soft capsules, hard capsules, powders, granules, liquids, pills, beverages, jelly, gummi, candy, cookies, biscuits, and energiba to achieve the effect of skin whitening, wrinkle improvement, and antioxidant activity. It can be prepared in various forms such as balanced nutrition foods.
본 발명의 상기 장미 태좌조직 배양물 또는 그 추출물은 피부 보호 및 개선 효과, 피부 미백 효과, 피부자극 완화, 피부 노화 및 주름의 예방 및 개선 효과, 피부 보호 및 피부의 염증 반응의 완화 효과, 또는 피부 장벽 기능의 회복 효과를 목적으로 식품 또는 음료에 첨가될 수 있다. 또한, 폴리페놀, 플라보노이드와 같은 생리활성물질을 함유하고 있어, 항산화능을 제공함으로 인해, 항산화 작용이 가지고 있는 신진대사 활성을 비롯한, 신체의 기능을 회복하고, 노화를 예방할 수 있다. 또한, 다양한 VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 및 TNF-α 의 싸이토카인을 발현하고 있고, 특히, 그 중 EGF, TGF-β1 및 TNF-α 에 대해 우수한 수준의 싸이토카인 발현능을 가지고 있어, 면역질환 개선의 기능을 할 수 있다. 이때, 식품 또는 음료 중의 상기 장미 태좌조직 배양 추출물의 양은 일반적으로 식품 전체 중량의 0.01 내지 5 중량%로 가할 수 있으며, 음료는 100㎖를 기준으로 0.01 내지 2g, 바람직하게는 0.3 내지 1g의 비율로 가할 수 있다.The rose thoracic tissue culture of the present invention or the extract thereof is a skin protection and improvement effect, skin whitening effect, skin irritation, skin aging and wrinkle prevention and improvement effect, skin protection and skin inflammatory response alleviation effect, or skin It may be added to foods or beverages for the purpose of restoring barrier function. In addition, it contains physiologically active substances such as polyphenols and flavonoids, and by providing antioxidant activity, it is possible to restore the body's functions, including metabolic activity of the antioxidant action, and prevent aging. In addition, it expresses various cytokines of VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 and TNF-α, and among them, specifically for EGF, TGF-β1 and TNF-α. It has an excellent level of cytokine expression and can function to improve immune diseases. At this time, the amount of the rosette tissue culture extract in the food or beverage can be generally added in 0.01 to 5% by weight of the total weight of the food, the beverage is in the ratio of 0.01 to 2g, preferably 0.3 to 1g based on 100ml Can be added.
본 발명에 있어서, 장미 태좌조직 배양물 또는 그 추출물은 정제수를 비롯한 무기용매, 유기용매를 이용하여 희석하거나, 희석되지 않은 상태로 함유할 수 있다.In the present invention, the rose thoracic tissue culture or its extract may be diluted with an inorganic solvent, an organic solvent including purified water, or may be contained in an undiluted state.
본 발명의 장미 태좌조직 배양물 또는 그 추출물이 첨가된 음료는 지시된 비율로 필수 성분으로서 상기 장미 태좌조직 배양물 또는 그 추출물을 포함하는 것 외에는 액체 성분에는 특별한 제한점은 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.상기의 천연 탄수화물의 예는 포도당, 과당, 갈락토오스, 만노스,등의 모노사카라이드; 말토스, 슈크로스 등의 디사카라이드; 덱스트린, 시클로덱스트린 등과 같은 통상적인 당; 및 자일리톨, 소르비톨, 에리트리톨, 등의 당알콜 등이 있다. 상기의 향미제로서 타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 등의 천연 향미제와 사카린, 아스파르탐 등의 합성 향미제를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 장미 태좌조직 배양 추출물을 포함하는 조성물 100㎖ 당 일반적으로 약 1 내지 20g, 바람직하게는 약 5 내지 12g이다.There is no particular limitation on the liquid component except that the rose fetal tissue culture of the present invention or the beverage to which the extract is added is an essential ingredient in the indicated ratio and the rose fetal tissue culture or its extract is not limited. Eggplant flavourant or natural carbohydrate, etc. may be contained as additional components. Examples of the natural carbohydrate include monosaccharides such as glucose, fructose, galactose, mannose, and the like; Disaccharides such as maltose and sucrose; Conventional sugars such as dextrin, cyclodextrin, and the like; And sugar alcohols such as xylitol, sorbitol, erythritol, and the like. As said flavoring agent, natural flavoring agents, such as tautin and a stevia extract (for example, rebaudioside A, glycyrrhizin, etc.), and synthetic flavoring agents, such as saccharin and aspartame, can be used advantageously. The ratio of the natural carbohydrate is generally about 1 to 20 g, preferably about 5 to 12 g, per 100 ml of the composition containing the rose fetal tissue culture extract of the present invention.
상기 외에 식품 및 음료는 여러 가지 영양제, 비타민류, 광물류(전해질), 합성 향료 및 천연 향료등의 풍미제, 착색제 및 향미증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 사용할 수 있다. 이러한 첨가제의 비율은 본 발명의 기능성 식품 100 중량% 당 0 내지 약 20 중량%의 범위에서 선택되는 것이 일반적이다.In addition to the above, food and beverages include various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic and natural flavors, colorants and flavor enhancers (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and salts thereof, Organic acids, protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, and the like. Others may contain pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. These components can be used independently. The proportion of such additives is generally selected from the range of 0 to about 20% by weight per 100% by weight of the functional food of the present invention.
본 발명의 장미 태좌조직 배양물 또는 추출물은 식품에 직접 첨가하여 사용할 수도 있으나, 대상 식품을 직접 장미 태좌조직 배양물 또는 그 추출물에 침지하거나 식품에 장미 태좌조직 배양 추출물을 분무하는 방법으로 피부 보호 및 개선 효과, 피부 미백 효과, 피부 노화 및 주름의 예방 및 개선 효과, 피부 보호 및 피부의 염증 반응의 완화 효과, 및 피부 장벽 기능의 회복 효과를 얻을 수 있다. 또한, 폴리페놀, 플라보노이드와 같은 생리활성물질을 함유하고 있어, 항산화능을 제공함으로 인해, 신체의 기능을 회복하고, 노화를 예방할 수 있다. 또한, 다양한 VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 및 TNF-α 싸이토카인을 발현하고 있고, 특히, 그 중, EGF, TGF-β1 및 TNF-α 에 대해 우수한 수준의 싸이토카인 발현능을 가지고 있어, 면역질환 개선의 기능을 할 수 있다. The rose fetal tissue culture or extract of the present invention may be used directly by adding to food, but the target food is directly immersed in the rose fetal tissue culture or its extract or by spraying the rose fetal tissue culture extract on food to protect the skin and The improvement effect, the skin whitening effect, the skin aging and the prevention and improvement effect of wrinkles, the skin protection, the alleviation effect of the inflammatory response of the skin, and the restoration effect of the skin barrier function can be obtained. In addition, it contains a physiologically active substance such as polyphenols and flavonoids, and by providing antioxidant activity, it is possible to restore the function of the body and prevent aging. In addition, various VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 and TNF-α cytokines are expressed, and among them, specifically, for EGF, TGF-β1 and TNF-α It has an excellent level of cytokine expression and can function to improve immune diseases.
본 발명에 있어서, 상기 기능성 식품은 분말, 과립, 정제, 소프트 캡슐, 하드캡슐, 액상,환, 젤리, 구미, 캔디, 쿠키, 비스킷, 밸런스 영양 식품 또는 음료 형태일 수 있으며, 이들 형태로의 제조기술은 하기 제조예들을 비롯하여 크게 제한됨 없이, 종래에 알려져 있는 방법을 이용하여 제조될 수 있다. In the present invention, the functional food may be in the form of powders, granules, tablets, soft capsules, hard capsules, liquid, pills, jelly, gummi, candy, cookies, biscuits, balanced nutritious foods or beverages, preparation in these forms Techniques can be prepared using methods known in the art, without being significantly limited, including the following preparations.
위와 같은 기능성 식품은, 본 발명에 따른 장미 태좌조직 배양물 또는 그 추출물이 식품첨가제로써 제공됨으로써 이루어질 수 있다. Functional foods as described above, it can be made by providing a rosette tissue culture or extract thereof according to the present invention as a food additive.
상기 식품첨가제에는 구연산, 후말산, 아디픽산, 젖산, 사과산 등의 유기산이나 인산나트륨, 인산칼륨, 산성피로인산염, 폴리인산염(중합인산염) 등의 인산염이나 폴리페놀, 카테킨(catechin), α-토코페롤, 로즈메리 추출물(rose mary extract), 감초 추출물, 키토산, 탄닌산, 피틴산 등의 천연 항산화제 중 어느 하나 또는 하나 이상을 추가로 포함할 수 있다. The food additives include organic acids such as citric acid, fumaric acid, adipic acid, lactic acid, malic acid, phosphates such as sodium phosphate, potassium phosphate, acid pyrophosphate and polyphosphate (polymeric phosphate), polyphenols, catechin, and α-tocopherol. It may further include any one or more of natural antioxidants, such as, rose mary extract, licorice extract, chitosan, tannic acid, phytic acid.
또한, 본 발명은 상기의 식품첨가제를 식품에 살균제, 향신료, 조미제, 여러가지 영양제, 비타민, 광물(전해질), 합성 향료 및 천연 향료등의 풍미제, 착색제 및 향미증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등 또는 식품소재의 필수원료로 사용하는 것을 특징으로 하는 식품첨가제의 이용방법을 제공한다. 이때 식품첨가제는 식품을 침지, 분무 또는 혼합하여 상기 식품에 첨가할 수 있으며, 이러한 첨가제의 비율은 그렇게 중요하진 않지만 전체 조성물 100중량부에 대하여, 본 발명의 장미 태좌조직 배양물 또는 그 추출물 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다. In addition, the present invention, the food additives in food, fungicides, spices, seasonings, various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic and natural flavors, colorants and flavor enhancers (cheese, chocolate, etc.), Pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, etc. It provides a method of using a food additive. At this time, the food additive may be added to the food by dipping, spraying or mixing the food, the ratio of these additives is not so important, but with respect to 100 parts by weight of the total composition, rose rotaceous tissue culture of the present invention or its
상기 식품은 곡류, 감자류, 두류, 채소류, 과일류, 어패류, 육류, 우유류, 해조류 등의 천연식품; 또는 빵류, 과자류, 라면, 아이스크림 등의 가공식품; 또는 음료 등이다.The food is natural foods such as cereals, potatoes, beans, vegetables, fruits, seafood, meat, milk, seaweeds; Or processed foods, such as bread, confectionery, ramen, and ice cream; Or drinks.
또 다른 관점에서, 본 발명은 장미 태좌조직의 배양물 또는 그 추출물이 우수한 항산화능을 가짐으로써, 이러한 배양물 또는 추출물을 함유하는 항산화용 조성물에 관한 것이다. 이러한 항산화용 조성물은, 신진대사의 기능을 촉진하고, 신체의 기능을 회복하고, 노화를 예방할 수 있다. 또한, 다양한 VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 및 TNF-α 싸이토카인을 발현하고 있고, EGF, TGF-β1 및 TNF-α 에 대해 우수한 수준의 싸이토카인 발현능을 가지고 있어, 면역질환 개선의 기능을 할 수 있으므로, 따라서, 이러한 항산화용 조성물은 항노화 조성물, 면역질환 개선용 조성물의 형태를 포함할 수 있다.
In another aspect, the present invention relates to a composition for antioxidant containing such a culture or extract, as the culture of the rose pollen tissue or extract thereof has excellent antioxidant capacity. Such an antioxidant composition can promote the function of metabolism, restore the function of the body, and prevent aging. In addition, it expresses various VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 and TNF-α cytokines and expresses high levels of cytokines for EGF, TGF-β1 and TNF-α. Since it has the ability to function to improve immune diseases, such an antioxidant composition may thus include an anti-aging composition and a form for improving immune diseases.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.
특히, 이하의 실시예에서는 장미 태좌 조직 배양 추출물에 관한 효능을 확인하였으나, 추출물이 아닌 배양물에 대해서도 이러한 효과가 있음은 당업자에게 자명할 것이다.
In particular, in the following examples, but confirmed the efficacy of the rosette left tissue culture culture extract, it will be apparent to those skilled in the art that such an effect even for the non-extract culture.
본 발명에 따른 장미 Roses according to the invention 태좌조직Tissue 배양 추출물의 제조 Preparation of Culture Extracts
1.1 장미(Rosa Damascena) 태좌조직의 분리 1.1 Rosa Damascena ) Isolation of the tissue
배양을 위해서, 장미꽃 꽃봉오리내의 밑씨, 씨방을 70 % 에탄올 및 0.5 % sodium hypochlorite로 5분간 멸균 소독하고, 멸균수로 여러 차례 씻어줬다. 조심스럽게 핀셋을 이용하여 씨방벽을 벗겨내고, 태좌를 분리하여 5% Sucrose가 포함된 MS 배지(Duchefa, Cat# M0256)에서 2~ 3주간 배양하였다. For cultivation, seed seeds and ovaries in rose buds were sterilized for 5 minutes with 70% ethanol and 0.5% sodium hypochlorite and washed several times with sterile water. Carefully peeled the seed barrier using tweezers, separated the urine and incubated for 2 to 3 weeks in MS medium (Duchefa, Cat # M0256) containing 5% Sucrose.
1.2 분리된 장미 태좌조직의 배양 및 대량생산1.2 Cultivation and Mass Production of Separated Rosettes
무균적으로 분리된 장미 태좌조직을 5% Sucrose가 포함된 MS배지에서 2~ 3주의 일정기간 간격으로 계대 배양하였다. 이후, 풍선형 생물반응기(㈜삼성과학)를 이용하여 Agar를 제외한 동일한 조성의 액체 배지에서 온도 25 ℃, 공기공급량을 0.1vvm으로 일정하게 조절하며 14일 간격으로 배양·증식하여 대량생산하였다. Aseptic isolated rosettes were passaged at intervals of 2 to 3 weeks in MS medium containing 5% Sucrose. Thereafter, using a balloon-type bioreactor (Samsung Science), the liquid medium of the same composition, except for Agar, was adjusted to a temperature of 25 ° C., and the air supply amount was adjusted to 0.1 vmv at 14 days intervals, followed by incubation and proliferation every 14 days.
1.3 장미 태좌조직 배양 추출물의 제조1.3 Preparation of Rose Fetal Tissue Culture Extracts
증식된 장미 태좌조직 배양물을 수확하여 깨끗한 티슈로 충분히 수분을 제거한 후 60℃로 2일 동안 건조기에서 건조하였다. 건조된 장미 태좌조직 배양물 분말 100g을 용기에 담고, 정제수 10 L를 넣은 후, 초음파 발생기(Elma, Transsonic 1040/H)를 사용하여 40kHz에서 60분 동안 초음파 추출을 시행하고, 65℃에서 2 시간 동안 교반하여 반응시킨 후, 열탕증류기에서 8 ~ 48시간동안, 80 ~100 ℃로 가열하여 열수 추출물을 얻었다. 추출 후, mesh로 여과하여 고형분을 제거하고, 장미 태좌조직 배양 추출물을 제조하였다.
The cultured rose thoracic tissue culture was harvested, dried with clean tissue, and dried in a dryer at 60 ° C. for 2 days. 100 g of dried rosette tissue culture powder was placed in a container, and 10 L of purified water was added thereto, followed by ultrasonic extraction at 40 kHz for 60 minutes using an ultrasonic generator (Elma, Transsonic 1040 / H), followed by 2 hours at 65 ° C. After stirring for a while, the mixture was heated for 8 to 48 hours and heated to 80 to 100 ° C. in a hot water distillation unit to obtain a hot water extract. After extraction, the solids were removed by filtration through a mesh to prepare a rosette tissue culture extract.
비교예Comparative example 1: 장미 꽃잎 추출물의 제조 1: Preparation of Rose Petal Extract
장미 꽃잎을 수확하여 60℃로 2일 동안 건조기에서 충분히 건조하였다. 건조된 장미 꽃잎 100g을 용기에 담고, 정제수 10 L를 넣은 후, 초음파 발생기(Elma, Transsonic 1040/H)를 사용하여 40kHz에서 60분 동안 초음파 추출을 시행하고, 65℃에서 2 시간 동안 교반하여 반응시킨 후, 열탕증류기에서 8 ~ 48시간동안, 80 ~100 ℃로 가열하여 열수 추출물을 얻었다. 추출 후, mesh로 여과하고, 고형분을 제거하여, 장미 추출물을 제조하였다.
The rose petals were harvested and dried sufficiently in a drier at 60 ° C. for 2 days. 100 g of dried rose petals were placed in a container, and 10 L of purified water was added thereto, followed by ultrasonic extraction at 40 kHz for 60 minutes using an ultrasonic generator (Elma, Transsonic 1040 / H), followed by stirring at 65 ° C. for 2 hours. After heating, the mixture was heated at 80 to 100 ° C. for 8 to 48 hours in a boiling water distillation unit to obtain a hot water extract. After extraction, the resultant was filtered through a mesh and solids were removed to prepare a rose extract.
실험예Experimental Example 1: 본 발명에 따른 장미 1: rose according to the invention 태좌조직Tissue 배양 추출물의 세포 성장 및 증식에 미치는 영향 시험 Influence test on cell growth and proliferation of culture extract
본 발명에 따른 장미 태좌조직 배양 추출물의 피부 세포의 증식 활성을 알아보기 위하여, 인간각질형성 세포(Human Skin Keratinocyte, HaCaT)는 ATCC(American Type Culture Collection)에서 분주 받아서 배양하였다. 세포를 1×104cells/ml의 농도로 하여 24 well 배양판에 접종하였다. 배지는 10 % FBS를 함유한 DMEM(Dubelcco'S Modified Eagle Medium, BRL,USA)을 사용하였다. 10% FBS를 함유하는 DMEM에서 48시간 배양하여 배양용기 표면적의 25 ~ 30%만큼 배양되면, 실시예 1에서 제조된 장미 태좌조직 배양 추출물이 0.1 % ~ 5 중량% 함유된 FBS-free DMEM으로 교체하여 24시간 더 배양하였다. 배양 후 3-(4,5-디메틸티아졸-2-일)-2,5-디페닐 테트라졸리움 브롬화물 (MTT, Sigma M5655, USA) 용액 (2.5 mg/ml)을 50㎕ 첨가하고 3시간동안 추가로 배양한 후 상등액을 제거하고, 각 well 당 200 ㎕의 Dimethylsulfoxide (DMSO, Sigma D2650, USA)용액을 가한 후 20분간 교반하여 형성된 포르마잔(formazan) 결정을 녹인 다음, 100㎕ 씩을 96 well 로 취하여 Enzyme-Linked Immunosorbent Assay (ELISA)로 570 nm 에서 흡광도를 측정하였다. 피부 세포의 증식 활성 정도는 순수한 물을 사용한 대조군의 흡광 강도를 기준으로 하기 수학식에 따라 계산하여 백분율로 표시하였다.In order to determine the proliferative activity of the skin cells of the rosette tissue culture culture extract according to the present invention, human keratinocytes (Human Skin Keratinocyte, HaCaT) were cultured by aliquoting from the American Type Culture Collection (ATCC). Cells were seeded in 24 well culture plates at a concentration of 1 × 10 4 cells / ml. Medium was used DMEM (Dubelcco'S Modified Eagle Medium, BRL, USA) containing 10% FBS. After 48 hours of incubation in DMEM containing 10% FBS and incubated by 25 to 30% of the surface of the culture vessel, the rosette tissue culture extract prepared in Example 1 was replaced with FBS-free DMEM containing 0.1% to 5% by weight. And further incubated for 24 hours. After incubation, 50 µl of 3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide (MTT, Sigma M5655, USA) solution (2.5 mg / ml) was added and 3 hours After further incubation, the supernatant was removed, 200 μl of Dimethylsulfoxide (DMSO, Sigma D2650, USA) solution was added to each well, followed by stirring for 20 minutes to dissolve the formazan crystals formed. The absorbance was measured at 570 nm with an Enzyme-Linked Immunosorbent Assay (ELISA). The degree of proliferative activity of the skin cells was calculated as a percentage based on the following formula based on the absorbance intensity of the control group using pure water.
[수학식 1][Equation 1]
세포증식효과(%) = (추출물 처리시의 흡광도/대조군의 흡광도) × 100Cell growth effect (%) = (absorbance at extract treatment / absorbance of control) × 100
추출물Rose petals
extract
태좌조직
배양
추출물rose
Tissue
culture
extract
상기 인간각질형성 세포(keratinocyte)를 이용한 세포성장 및 증식에 미치는 영향시험 결과, 표 1 및 도 1에 나타난 바와 같이, 5 중량% 장미 태좌조직 배양 추출물이 함유된 경우에는 124 %로 대조군과 비교하여 세포증식효과를 확인할 수 있었다. 1 중량% 장미 태좌조직 배양 추출물이 함유된 경우 대조군에 비해서 116 %의 증식 정도를 보였고, 0.5 중량%, 0.1 중량%의 장미 태좌조직 배양 추출물이 함유된 경우 대조군에 비해서 109%, 102%의 증식을 보였다. 따라서, 본 발명에 따른 장미 태좌조직 배양 추출물은 피부 세포성장과 증식의 활성화에 영향을 나타내었고, 이에 비해 태좌조직 배양물이 아닌 장미 꽃잎 추출물의 경우 세포 증식 효과가 미비하였다.
As a result of the effect on the growth and proliferation of the human keratinocytes (keratinocyte), as shown in Table 1 and Figure 1, when the 5% by weight rosette tissue culture extract containing 124% compared to the control group The cell proliferation effect could be confirmed. 1 wt% rose fetal tissue culture extract showed 116% growth compared to the control group, and 0.5 wt% and 0.1 wt% rose fetal tissue culture extract contained 109% and 102% growth compared to the control group. Showed. Therefore, the rose pollen tissue culture extract according to the present invention showed an effect on the skin cell growth and the activation of proliferation, whereas the rose petal extract, which is not the tissue of the left pollinate tissue culture, had insufficient cell proliferation effect.
실험예Experimental Example 2 : 본 발명에 따른 장미 2 rose according to the invention 태좌조직Tissue 배양 추출물의 Of culture extract 항산화능Antioxidant ability 효능 시험 Efficacy test
본 발명에 따른 장미 태좌조직 배양 추출물의 항산화능은 Antioxidant Assay Kit (Cayman, Ann Arbor, Mich.)를 사용하였고, 제조자의 지시에 따라 실험하였다.Antioxidant activity of the rose thoracic tissue culture extract according to the present invention was used as an Antioxidant Assay Kit (Cayman, Ann Arbor, Mich.) And was tested according to the manufacturer's instructions.
장미 태좌조직 배양 추출물의 항산화능(Antioxidative Capacity)은 Antioxidant Assay Kit (Cayman사, Cat No. 709001, Antioxidant Kit)를 이용하여, Trolox의 항산화능(Antioxidative Capacity)을 다양한 농도의 기준(standard)으로 하여, Trolox 농도로 전환시켜 측정하였다.Antioxidant Capacity of Rose's Peripheral Tissue Culture Extract was determined using Antioxidant Assay Kit (Cayman, Cat No. 709001, Antioxidant Kit). It was measured by conversion to Trolox concentration.
추출물Rose petals
extract
태좌조직
배양
추출물rose
Tissue
culture
extract
100 μM Vitamin CPositive control group
100 μM Vitamin C
그 결과, 표 2 및 도 2에 나타난 바와 같이, 장미 태좌조직 배양 추출물의 농도 의존적(Dose-Dependent)으로 항산화능이 증가하였다. 5 중량% 의 장미 태좌조직 배양 추출물은 양성대조군인 100 μM 비타민 C보다도 더 높은 항산화능(Antioxidative Potency)을 보임으로써 장미 태좌조직 배양 추출물의 높은 항산화능을 알수 있었다. 이에 비해 장미 꽃잎 추출물의 경우는 장미 태좌 조직 배양 추출물에 비해서는, 항산화능이 매우 낮았다.
As a result, as shown in Table 2 and Figure 2, the concentration of antioxidant rosette doeneun tissue culture extract (Dose-Dependent) increased the antioxidant capacity. The 5 wt% rosette tissue culture extract showed higher antioxidative potency than the
실험예Experimental Example 3: 본 발명에 따른 장미 3: rose according to the invention 태좌조직Tissue 배양 추출물의 주름개선(콜라겐 합성) 효과 시험 Wrinkle improvement (collagen synthesis) effect test of culture extract
인간섬유아세포(Human Skin Fibroblast)를 37℃, 5% CO2 배양기에서 일정한 습도를 유지하는 세포 배양기내에서 10% FBS, Penicillin(50U/ml), Streptomycin(50/ml)를 함유하는 DMEM(Dulbecco's Modified Eagle's Medium, Gibco, USA)으로 배양하여, 1×105개/ml로 24 well plate에 500㎕씩 분주한 다음 24시간 배양하였다. 대조군(DMEM 배지)과 0.1 ~ 5 중량%의 다양한 농도의 실시예 1의 장미 태좌조직 배양 추출물을 함유한 배지를 넣고 48시간동안 37℃, 5% CO2 배양기에서 배양하였다. 48시간 후, 배지의 상층액을 각각 20㎕을 취해 Procollagen Type I C-Peptide EIA Kit(PICP, Takara, Cat No. MK101)를 이용하여 측정함으로써 새로 합성된 콜라겐 양을 측정하였다. 비교예의 장미꽃잎 추출물과 상기한 방법과 동일한 방법으로 실험하여 결과를 얻었다. PICP양은 ng/1×105세포로 환산하였다. Human Skin Fibroblasts at 37 ° C., 5% CO 2 Incubated in Dulbecco's Modified Eagle's Medium, Gibco, USA (DMEM) containing 10% FBS, Penicillin (50 U / ml) and Streptomycin (50 / ml) in a cell incubator with constant humidity, 1 × 10 5 500 µl aliquots were injected into 24 well plates at dogs / ml and incubated for 24 hours. Insert the medium containing the control sample (DMEM medium) and rose fetal tissue culture extract of Example 1 in various concentrations of 0.1 to 5% by weight, 37 ℃, 5% CO 2 for 48 hours Lt; / RTI > After 48 hours, the amount of newly synthesized collagen was measured by taking 20 μl of the supernatant of the medium and measuring the resultant using a Procollagen Type I C-Peptide EIA Kit (PICP, Takara, Cat No. MK101). The results of experiments were obtained in the same manner as the above-described method of extracting rose petals of Comparative Examples. The PICP amount was converted into ng / 1 × 10 5 cells.
추출물Rose petals
extract
태좌조직
배양
추출물rose
Tissue
culture
extract
대조군 수치를 100으로 하여, 장미 꽃잎 추출물 처리군과 장미 태좌 조직 배양 추출물 처리군 및 양성대조군의 콜라겐 생합성 증가율은 표 3 및 도 3에 나타난 바와 같다. The control value was set at 100, and the increase rate of collagen biosynthesis of the rose petal extract treatment group, the rose thoracic tissue culture extract treatment group, and the positive control group was as shown in Table 3 and FIG. 3.
표 3 및 도 3에 나타난 바와 같이, 본 발명의 조성물은 장미 태좌조직 배양 추출물의 함량이 증가함에 따라 콜라겐의 생합성량이 증가함을 알 수 있고, 장미 추출물에 비해서도 본 발명의 조성물이 탁월한 콜라겐 합성 증진 효과를 나타냄을 알 수 있다.
As shown in Table 3 and Figure 3, the composition of the present invention can be seen that the biosynthesis amount of collagen increases as the content of the rose cadaver tissue culture extract is increased, the composition of the present invention is superior to the composition of the present invention as compared to the rose extract It can be seen that the effect.
실험예Experimental Example 4 : 본 발명에 따른 장미 4: rose according to the invention 태좌조직Tissue 배양 추출물의 Of culture extract 싸이토카인의Cytokine 발현 분석 실험 Expression assay
본 발명에 따른 장미 태좌조직 배양 추출물에 대한 싸이토카인의 발현율을 알아보기 위하여, 인간섬유아세포인 Fibroblast (Cell Lines Service, Germany)를 1×105cells/ml의 농도로 하여 24 well 배양판에 접종하였다. 10% FBS를 함유하는 DMEM(Dubelcco'S Modified Eagle Medium, BRL,USA)에서 배양하여 배양용기 표면적의 25 ~ 30%만큼 배양되면, 실시예 1에서 제조된 장미 태좌조직 배양 추출물이 1% 함유된 FBS-free DMEM, 대조군으로 사용된 FBS-free DMEM 으로 교체하여 48시간 더 배양하였다. HUMAN CYTOKINE ASSAY KIT(Millipore)을 사용하여 VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 및 TNF-α 의 싸이토카인의 발현율을 조사하였다. 실험방법은 HUMAN CYTOKINE ASSAY KIT의 지시에 따라 수행하였다.In order to determine the expression rate of cytokine in the rosette tissue culture extract according to the present invention, Fibroblast (Cell Lines Service, Germany), a human fibroblast, was inoculated in 24 well culture plates at a concentration of 1 × 10 5 cells / ml. . When cultured in DMEM (Dubelcco'S Modified Eagle Medium, BRL, USA) containing 10% FBS and incubated by 25-30% of the surface of the culture vessel, FBS- containing 1% of the rose fetal tissue culture extract prepared in Example 1 Free DMEM was replaced with FBS-free DMEM used as a control, and further incubated for 48 hours. The expression rates of cytokines of VEGF, EGF, FGF, TGF-β1, IL-1α, IL-6, IL-8 and TNF-α were investigated using HUMAN CYTOKINE ASSAY KIT (Millipore). Experimental method was carried out according to the instructions of HUMAN CYTOKINE ASSAY KIT.
상기 표 4와 도 4에 나타난 바와 같이, 싸이토카인의 발현율은 무처리한 대조군에 비해 1% 장미 태좌조직 배양 추출물을 처리하였을 경우, EGF, TGF-β1 및 TNF-α 가 유의적인 수준으로 발현함을 확인할 수 있었다. As shown in Table 4 and Figure 4, the expression rate of the cytokine is expressed in significant levels of EGF, TGF-β1 and TNF-α when treated with 1% rosette tissue culture extract compared to the untreated control group I could confirm it.
이러한 결과는, 본 발명의 장미 태좌조직 배양 추출물이 싸이토카인 발현 효과를 가짐으로써, 면역 조절제로써 기능할 수 있음을 의미한다.
These results indicate that the rose pollen tissue culture extract of the present invention has a cytokine expression effect, and thus can function as an immunomodulator.
실험예Experimental Example 5 : 본 발명에 따른 장미 5: rose according to the invention 태좌조직Tissue 배양 추출물의 생리활성물질 함량 분석 실험 Bioactive substance content analysis experiment of culture extract
(1) 총 폴리페놀의 함량(Total polyphenol content)은 분석방법으로 널리 사용되고 있는 Folins-Denis 방법으로 측정하였다. 장미 태좌 조직배양 추출물 0.5 ml 에 Folin reagent 0.5 ml 를 가하고 3분간 정치한 다음 0.5 ml의 10 % Na2CO3 용액을 가하였다. 이 혼합액을 1시간 동안 정치한 후 분광광도계 (UV/VIS spectrometer, Jasco, Japan)를 사용하여 760 nm에서 흡광도를 측정하였다. 시료의 총폴리페놀 함량은 gallic acid로 표준곡선을 작성하여 mM gallic acid equivalent 로 나타내었다.(1) Total polyphenol content was measured by Folins-Denis method which is widely used as an analytical method. 0.5 ml of Folin reagent was added to 0.5 ml of rosette tissue culture extract and allowed to stand for 3 minutes, and then 0.5 ml of 10% Na 2 CO 3 solution was added thereto. After the mixture was left for 1 hour, the absorbance was measured at 760 nm using a spectrophotometer (UV / VIS spectrometer, Jasco, Japan). The total polyphenol content of the sample was expressed as mM gallic acid equivalent by preparing a standard curve with gallic acid.
추출물Rose petals
extract
태좌조직
배양
추출물rose
Tissue
culture
extract
표 5에 나타난 바와 같이, 장미 태좌조직 배양 추출물이 장미꽃잎 추출물에 비해 농도 의존적으로 총 폴리페놀의 함량이 증가함을 확인할 수 있었다. As shown in Table 5, it was confirmed that the total concentration of polyphenols increased in a concentration-dependent manner compared with the rose petal culture extract.
(2) 총 플라보노이드의 함량(Total flavonoid content)은 Moreno 등의 방법에 따라 측정하였다. 장미 태좌 조직 배양 추출물 0.5 mL에 10 % aluminum nitrate 0.1 mL를 첨가한 후 1 M potassium acetate 0.1 mL, ethanol 4.3 mL를 순서대로 혼합하고 상온에서 40분간 반응시켜 415 nm에서 흡광도를 측정하였으며 총 플라보노이드 함량은 catechin을 표준물질로 한 표준곡선을 이용하여 장미 태좌 조직 배양 추출물 g당 함량으로 계산하였다. (2) Total flavonoid content was measured according to the method of Moreno et al. After adding 0.1 mL of 10% aluminum nitrate to 0.5 mL of rosette tissue culture extract, 0.1 mL of 1 M potassium acetate and 4.3 mL of ethanol were mixed in this order, and the absorbance was measured at 415 nm by reacting for 40 minutes at room temperature. Using a standard curve with catechin as a standard, it was calculated as the content per gram of rose pollen tissue culture extract.
추출물Rose petals
extract
태좌조직
배양
추출물rose
Tissue
culture
extract
표 6에 나타난 바와 같이, 장미 태좌조직 배양 추출물이 장미 꽃잎추출물에 비해 농도 의존적으로 총 플라보노이드 함량이 증가함을 확인할 수 있었다. As shown in Table 6, it was confirmed that the total concentration of flavonoids increased in a concentration-dependent manner compared to the rose petal extract of rose cadaver tissue.
이러한 폴리페놀, 플라보노이드는 항산화효과가 있어, 노화를 방지하는 물질로써, 본 발명의 장미 태좌조직 배양 추출물은 이러한 폴리페놀, 플라보노이드를 함유하고 있으므로, 생체의 기능을 증진시키고, 신체를 활성화시키는 기능이 있음을 확인하였다.
Such polyphenols and flavonoids have an antioxidant effect, and as a substance to prevent aging, rose fetal tissue culture extract of the present invention contains such polyphenols and flavonoids, and thus, functions to enhance the function of the living body and activate the body. It was confirmed that there is.
화장료 조성물의 제조Preparation of Cosmetic Composition
본 발명의 장미 태좌조직 배양 추출물를 유효성분으로 함유하는 화장품으로 영양화장수, 크림, 에센스 등의 유화 제형의 화장품 및 유연화장수 등의 가용화 제형의 화장품을 제조하였다.As cosmetics containing the rose locust tissue culture extract of the present invention as an active ingredient, cosmetics of emulsified formulations such as nutrient cosmetics, creams and essences, and cosmetics of solubilized formulations such as softening cosmetics were prepared.
제조예Manufacturing example 2-1: 화장수 2-1: lotion
다음 처방에 따라 통상의 화장수 제조 방법에 따라 제조하였다.It was prepared according to a conventional lotion preparation method according to the following prescription.
제조예Manufacturing example 2-2: 에센스 2-2: essence
다음 처방에 따라 통상의 에센스 제조 방법에 따라 제조하였다.It was prepared according to a conventional essence preparation method according to the following prescription.
제조예Manufacturing example 2-3: 로션 2-3: lotion
다음 처방에 따라 통상의 로션 제조 방법에 따라 제조하였다.It was prepared according to the conventional lotion preparation method according to the following prescription.
제조예Manufacturing example 2-4: 크림 2-4: cream
다음 처방에 따라 통상의 크림 제조 방법에 따라 제조하였다.It was prepared according to the conventional cream preparation method according to the following prescription.
제조예Manufacturing example 2-5: 젤 2-5: gel
다음 처방에 따라 통상의 젤 제조 방법에 따라 제조하였다.It was prepared according to the conventional gel preparation method according to the following prescription.
기능성 식품의 제조 Preparation of Functional Foods
본 발명의 장미 태좌조직 배양 추출물을 포함하는 식품들을 다음과 같이 제조하였다.Foods containing the rose fetal tissue culture extract of the present invention were prepared as follows.
제조예Manufacturing example 3-1: 밀가루 식품 3-1: Wheat Flour Food
본 발명의 장미 태좌조직 배양 추출물 0.5~5.0 중량부를 밀가루에 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하였다.0.5 to 5.0 parts by weight of the rose perilla tissue culture extract of the present invention was added to the flour, and bread, cake, cookies, crackers and noodles were prepared using the mixture.
제조예Manufacturing example 3-2: 3-2: 스프soup 및 육즙( And juicy ( graviesgravies ))
본 발명의 장미 태좌조직 배양 추출물을 0.1~5.0 중량부를 스프 및 육즙에 첨가하여 건강 증진용 육가공 제품, 면류의 수프 및 육즙을 제조하였다.0.1 to 5.0 parts by weight of the rose thalca tissue culture extract of the present invention was added to soups and broths to prepare meat products for health promotion, soups and noodles for noodles.
제조예Manufacturing example 3-3: 그라운드 비프( 3-3: Ground Beef groundground beefbeef ))
본 발명의 장미 태좌조직 배양 추출물을 10 중량부를 그라운드 비프에 첨가하여 건강 증진용 그라운드 비프를 제조하였다.10 parts by weight of the rose perilla tissue culture extract of the present invention was added to the ground beef to prepare a ground beef for health promotion.
제조예Manufacturing example 3-4: 유제품( 3-4: Dairy Products dairydairy productsproducts ))
본 발명의 장미 태좌조직 배양 추출물을 5~10 중량부를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.5 to 10 parts by weight of the rose perilla tissue culture extract of the present invention was added to milk, and various dairy products such as butter and ice cream were prepared using the milk.
제조예Manufacturing example 3-5: 곡물 분말 식품( 3-5: grain powder food ( 선식Wire )의 제조Manufacturing
현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다. 검정콩, 검정깨, 들깨도 공지의 방법으로 쪄서 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다. 본 발명의 장미 태좌조직 배양 추출물를 진공 농축기에서 감압농축하고, 분무, 열풍건조기로 건조하여 얻은 건조물을 분쇄기로 입도 60 메쉬로 분쇄하여 건조분말을 얻었다.Brown rice, barley, glutinous rice, and yulmu were dried by a known method and dried, and the mixture was granulated to a powder having a particle size of 60 mesh. Black soybeans, black sesame seeds, and perilla seeds were steamed and dried by a conventional method, and then they were prepared into powder having a particle size of 60 mesh by a pulverizer. The rose pollens tissue culture extract of the present invention was concentrated under reduced pressure in a vacuum concentrator, and the dried product obtained by drying with a spray and a hot air dryer was pulverized with a particle size of 60 mesh to obtain a dry powder.
상기에서 제조한 곡물류, 종실류 및 장미 태좌조직 배양 추출물을 다음의 비율로 배합하여 제조하였다.The grains, seeds, and rose pollen tissue culture extracts prepared above were formulated in the following ratios.
곡물류(현미 30 중량부, 율무 15 중량부, 보리 20 중량부),(30 parts by weight of brown rice, 15 parts by weight of yulmu, 20 parts by weight of barley)
종실류(들깨 7 중량부, 검정콩 8 중량부, 검정깨 7 중량부),Seeds (7 parts by weight of perilla, 8 parts by weight of black beans, 7 parts by weight of black sesame seeds)
장미 태좌조직 배양 추출물(3 중량부)Rose thalca tissue culture extract (3 parts)
상기 제법에서 얻은 곡물 분말 식품(선식)에 적량의 물등을 가해 혼합하여, 먹을수 있다.An appropriate amount of water, etc. may be added to the grain powder food (wire) obtained by the said manufacturing method, and it may eat.
제조예Manufacturing example 3-6: 음료 3-6: drink
6-1) 건강음료의 제조6-1) Manufacture of Health Beverage
액상과당(0.5%), 올리고당(2%), 설탕(2%), 식염(0.5%), 물(75%)과 같은 부재료와 본 발명의 장미 태좌조직 배양 추출물 5 g을 균질하게 배합하여 순간 살균을 한 후 이를 유리병, 패트병 등 소포장 용기에 포장하여 제조하였다.Homogeneous blend of subsidiary materials such as liquid fructose (0.5%), oligosaccharide (2%), sugar (2%), salt (0.5%), water (75%), and 5 g of rosette tissue culture extract of the present invention After sterilization, it was prepared by packing it in a small packaging container such as a glass bottle or a plastic bottle.
6-2) 야채쥬스의 제조6-2) Preparation of Vegetable Juice
본 발명의 장미 태좌조직 배양 추출물 5 g을 토마토 또는 당근 쥬스 1,000 ㎖에 가하여 야채쥬스를 제조하였다.Vegetable juice was prepared by adding 5 g of the rosette tissue culture extract of the present invention to 1,000 ml of tomato or carrot juice.
6-3) 과일쥬스의 제조6-3) Preparation of Fruit Juice
본 발명의 장미 태좌조직 배양 추출물 1 g을 사과 또는 포도 쥬스 1,000 ㎖ 에 가하여 과일쥬스를 제조하였다.Fruit juice was prepared by adding 1 g of the rosette tissue culture extract of the present invention to 1,000 ml of apple or grape juice.
제조예Manufacturing example 3-7: 소프트캡슐 3-7: Soft Capsule
홍화유, 옥수수 기름, 면실유, 땅콩 기름, 유채 기름, 참기름, 쌀 배아 오일, 콩기름, 해바라기 기름, 달맞이꽃 오일, 아보카도 오일, 아마인유, 들깨 기름 등 식물성 기름에 본 발명의 장미 태좌 조직 배양 추출물을 25 % 혼합하고, 그위에 비타민과 미네랄 및 각종 건강 기능 소재를 그 목적으로하는 기능에 맞게 적절하게 혼합하여 밀랍이나 글리세린 지방산 에스테르 등의 유화제를 함유한 슬러리 상태로 조정했다. 그 슬러리 280mg을 내용물로, 젤라틴에 글리세린을 적당량 함유하고 피막 또는 가공 전분, 글리세린, 증점 다당류로 이루어진 식물성 피막으로 감싸고 전체 량 450mg 소프트 캡슐을 열 형성했다. Safflower oil, corn oil, cottonseed oil, peanut oil, rapeseed oil, sesame oil, rice germ oil, soybean oil, sunflower oil, evening primrose oil, avocado oil, linseed oil, perilla oil, etc. The mixture was mixed with vitamins, minerals, and various health functional materials appropriately to suit the intended function, and adjusted to a slurry state containing emulsifiers such as beeswax and glycerin fatty acid esters. 280 mg of the slurry was used as the contents, and gelatin contained an appropriate amount of glycerin, and was encapsulated with a film or a vegetable film composed of processed starch, glycerin, and thickened polysaccharides, and a total amount of 450 mg soft capsule was thermally formed.
제조예Manufacturing example 3-8 : 3-8: 하드hard 캡슐 capsule
본 발명의 장미 태좌 조직 배양 추출물 180mg 대해 덱스트린 40mg을 혼합하고, 그 분말 220mg을 내용물로 해서, 젤라틴 또는 셀룰로오스 등으로 구성되는 하드 캡슐에 넣었다.40 mg of dextrin was mixed with 180 mg of rosette tissue culture extract of the present invention, and 220 mg of the powder was used as the contents, and placed in a hard capsule made of gelatin or cellulose.
이상으로 본 발명의 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.
As described above in detail a specific part of the content of the present invention, for those skilled in the art, such a specific description is only a preferred embodiment, which is not limited by the scope of the present invention Will be obvious. Accordingly, the actual scope of the present invention will be defined by the appended claims and their equivalents.
Claims (20)
(a) 장미의 씨방내의 태좌조직을 분리하여 배양하는 단계; 및
(b) 상기 (a)단계에서 얻어진 배양물 또는 그 추출물을 함유하는 조성물을 제조하는 단계. A method for preparing a skin external composition for skin improvement comprising a culture of rose pollen tissue or an extract thereof comprising the following steps:
(a) separating and incubating the tissues in the ovary of the rosette; And
(b) preparing a composition containing the culture or extract thereof obtained in step (a).
Antioxidant composition containing the culture of the rose thoracic tissue or extract thereof.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2012004878A MY157534A (en) | 2011-06-07 | 2011-06-07 | Composition for skin external application and functional food containing rose placenta tissue culture or extract thereof |
PCT/KR2011/004120 WO2012169664A1 (en) | 2011-06-07 | 2011-06-07 | External dermal agent and functional food containing rose placenta tissue-cultured product or extract thereof |
KR1020110054325A KR101372789B1 (en) | 2011-06-07 | 2011-06-07 | Composition for Skin External Application Comprising Culture Extract of Rosa Placenta and Functional Food Comprising the Same |
SG2012084125A SG186061A1 (en) | 2011-06-07 | 2011-06-07 | Composition for skin external application and functional food containing rose placenta tissue culture or extract thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110054325A KR101372789B1 (en) | 2011-06-07 | 2011-06-07 | Composition for Skin External Application Comprising Culture Extract of Rosa Placenta and Functional Food Comprising the Same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120135550A true KR20120135550A (en) | 2012-12-17 |
KR101372789B1 KR101372789B1 (en) | 2014-03-12 |
Family
ID=47296209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110054325A KR101372789B1 (en) | 2011-06-07 | 2011-06-07 | Composition for Skin External Application Comprising Culture Extract of Rosa Placenta and Functional Food Comprising the Same |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR101372789B1 (en) |
MY (1) | MY157534A (en) |
SG (1) | SG186061A1 (en) |
WO (1) | WO2012169664A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150049078A (en) * | 2013-10-28 | 2015-05-11 | 주식회사 동양생명과학 | Cosmetic Composition including Rosa davurica Pall Callus Cultured in medicum containing mineral water |
KR20150054614A (en) * | 2013-11-12 | 2015-05-20 | 주식회사 엘지생활건강 | Method for manufacturing cultured bean placenta extract having high content of isoflavone |
KR20150104754A (en) * | 2014-03-06 | 2015-09-16 | 주식회사 바이오에프디엔씨 | Anti-aging and Enhancing Skin Barrier Function composition for skin external application comprising Asparagales Placenta Cell Culture Extract |
KR20160057809A (en) * | 2014-11-14 | 2016-05-24 | 재단법인 홍천메디칼허브연구소 | Mist composition with the extract of wood-cultivated ginseng for skin moisturizing |
WO2017082592A1 (en) * | 2015-11-09 | 2017-05-18 | 한국식품연구원 | Method for obtaining rosae multiflorae fructus extract comprising polyphenol substance from rosae multiflorae fructus at high yield |
KR20210136217A (en) * | 2020-05-06 | 2021-11-17 | 연세대학교 산학협력단 | Cosmetics for Skin Cell Regeneration |
WO2021246684A1 (en) * | 2020-06-04 | 2021-12-09 | 주식회사 엑소코바이오 | Composition for anti-inflammation, wound healing or wound healing promotion, comprising rose stem cell-derived exosomes as active ingredient |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105232687A (en) * | 2015-11-30 | 2016-01-13 | 湖南省广林农业科技开发有限公司 | Extraction method for effective ingredients in roses and rose hips |
KR101966374B1 (en) | 2017-11-28 | 2019-04-05 | 이노팜 주식회사 | Composition for accelerating wound healing comprising and Aquilaria crassna extract and β-Glucan |
CN112512499B (en) | 2018-07-26 | 2023-07-28 | 韩国外泌体生技有限公司 | Cosmetic composition comprising rose stem cell-derived exosomes as active ingredient |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4025600B2 (en) * | 2002-08-12 | 2007-12-19 | 山川貿易株式会社 | Topical skin preparation |
JP2006273811A (en) * | 2005-03-30 | 2006-10-12 | Naris Cosmetics Co Ltd | Maillard reaction inhibitor |
KR20110017566A (en) * | 2009-08-14 | 2011-02-22 | (주)아모레퍼시픽 | Composition containing extracts of rose |
-
2011
- 2011-06-07 MY MYPI2012004878A patent/MY157534A/en unknown
- 2011-06-07 KR KR1020110054325A patent/KR101372789B1/en active IP Right Grant
- 2011-06-07 WO PCT/KR2011/004120 patent/WO2012169664A1/en active Application Filing
- 2011-06-07 SG SG2012084125A patent/SG186061A1/en unknown
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150049078A (en) * | 2013-10-28 | 2015-05-11 | 주식회사 동양생명과학 | Cosmetic Composition including Rosa davurica Pall Callus Cultured in medicum containing mineral water |
KR20150054614A (en) * | 2013-11-12 | 2015-05-20 | 주식회사 엘지생활건강 | Method for manufacturing cultured bean placenta extract having high content of isoflavone |
KR20150104754A (en) * | 2014-03-06 | 2015-09-16 | 주식회사 바이오에프디엔씨 | Anti-aging and Enhancing Skin Barrier Function composition for skin external application comprising Asparagales Placenta Cell Culture Extract |
KR20160057809A (en) * | 2014-11-14 | 2016-05-24 | 재단법인 홍천메디칼허브연구소 | Mist composition with the extract of wood-cultivated ginseng for skin moisturizing |
WO2017082592A1 (en) * | 2015-11-09 | 2017-05-18 | 한국식품연구원 | Method for obtaining rosae multiflorae fructus extract comprising polyphenol substance from rosae multiflorae fructus at high yield |
KR20210136217A (en) * | 2020-05-06 | 2021-11-17 | 연세대학교 산학협력단 | Cosmetics for Skin Cell Regeneration |
WO2021246684A1 (en) * | 2020-06-04 | 2021-12-09 | 주식회사 엑소코바이오 | Composition for anti-inflammation, wound healing or wound healing promotion, comprising rose stem cell-derived exosomes as active ingredient |
Also Published As
Publication number | Publication date |
---|---|
MY157534A (en) | 2016-06-15 |
WO2012169664A1 (en) | 2012-12-13 |
KR101372789B1 (en) | 2014-03-12 |
SG186061A1 (en) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101372789B1 (en) | Composition for Skin External Application Comprising Culture Extract of Rosa Placenta and Functional Food Comprising the Same | |
KR20210087405A (en) | Compositions Containing Plant Extracts | |
JP5577443B2 (en) | Extract of rose placenta tissue culture and method for producing the same | |
KR101839407B1 (en) | Composition comprising actinidia polygama extract for improving skin whitening or wrinkle | |
KR101896908B1 (en) | Method for preparing camellia infused oil and cosmetic composition comprising the same | |
KR101333676B1 (en) | Cosmetic composition for reducing skin pore size and secreting sebum containing the extract of oenothera odorata jacq., pueraria radix, pine tree leaves and ulmus pumila l | |
KR101377411B1 (en) | Extracts from Smilacina japonica A. Gray, or Arabis glabra Bernh Having Potent Anti-Inflammatory Activity | |
KR101607503B1 (en) | Composition for anti-oxidant, skin whitening and improving wrinkle comprising Mesembryanthemum Crystallinum callus extract | |
KR101473940B1 (en) | Hair cosmetic composition for preventing hair loss and improving the scalp comprising the complex extracts of Swertia japonica MAKINO, Paeonia lactiflora, quisetum arvense L. and peach | |
KR102221750B1 (en) | A manufacturing method of nipa fruticans wurmb composition having a high polyphenol and flavonoid contents and a cosmetic composition having nipa fruticans wurmb composition | |
KR102561258B1 (en) | Composition for controlling sebum and improving pore comprising Jasminum Officinale, Salix Alba (willow) bark and Solanum melogena fruit extract | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR101863117B1 (en) | Composition comprising Androsace umbellate extract, Vaccinium oldhami extract, and Deutzia crenata extract | |
KR102557372B1 (en) | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Extracts of Rosa davurica Pall as Active Ingredient | |
KR102283946B1 (en) | Anti-inflammation Compound derived from Yuja and Isolating Method Thereof | |
KR101963597B1 (en) | Cosmetic Composition for Anti-oxidation, Whitening and Moisturizing Containing Althaea rosea or Damnacanthus major | |
KR101487942B1 (en) | The method for manufacturing panax ginseng composite by using the punica granatum concentrate for skin whitening, and the panax ginseng composite made by the method | |
KR101797567B1 (en) | Composition for preventing or improving of skin wrinkle comprising a extracts or fractions of Euphorbia maculata or Euphorbia supina | |
KR20140130401A (en) | A method of preparing extract improving anti-oxidative activity | |
KR102702592B1 (en) | Composition for anti-microbial and anti-wrinkle comprising extract of in vitro cultured plantlet of Black currant having antioxidant activity as effective component | |
KR102366932B1 (en) | Composition with Antioxidant, Anti-Inflammation, Skin Moisturizing, Anti-Wrinkle, and Skin Regeneration Property Comprising Complex Extract of Hibiscus Syriacus Softened Petal as Active Ingredient | |
KR102133479B1 (en) | Cosmetic composition containing domestic natural extract | |
KR102313083B1 (en) | An anti-oxidative composition comprising an extract of Hydrangea petiolaris or a fraction thereof as an active ingredient | |
KR102225585B1 (en) | Cosmetic Compositions for Improving Skin Wrinkle Containing Processing Product of Ginseng Steaming Extract | |
KR101890725B1 (en) | A composition for antioxidation comprising extracts of sedirea japonica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170102 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180111 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20191224 Year of fee payment: 7 |